Selected publications

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2020

• Nekvindova, J; Mrkvicova, A; Zubanova, V; Vaculova, AH; Anzenbacher, P; Soucek, P; Radova, L; Slaby, O; Kiss, I; Vondracek, J; Spicakova, A; Bohovicova, L; Fabian, P; Kala, Z; Palicka, V , 2020: Hepatocellular carcinoma: gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450. BIOCHEMICAL PHARMACOLOGY , doi: 10.1016/j.bcp.2020.113912
• Mancikova, V; Peschelova, H; Kozlova, V; Ledererova, A; Ladungova, A; Verner, J; Loja, T; Folber, F; Mayer, J; Pospisilova, S; Smida, M, 2020: Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia. JOURNAL FOR IMMUNOTHERAPY OF CANCER 8(1), doi: 10.1136/jitc-2019-000471
• Noskova, H; Kyr, M; Pal, K; Merta, T; Mudry, P; Polaskova, K; Ivkovic, TC; Adamcova, S; Hornakova, T; Jezova, M; Kren, L; Sterba, J; Slaby, O, 2020: Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?. CANCERS 12(1), doi: 10.3390/cancers12010230
• Kozlova, V; Ledererova, A; Ladungova, A; Peschelova, H; Janovska, P; Slusarczyk, A; Domagala, J; Kopcil, P; Vakulova, V; Oppelt, J; Bryja, V; Doubek, M; Mayer, J; Pospisilova, S; Smida, M, 2020: CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells. PLOS ONE 15(3), doi: 10.1371/journal.pone.0229170
• Polaskova, K; Merta, T; Martincekova, A; Zapletalova, D; Kyr, M; Mazanek, P; Krenova, Z; Mudry, P; Jezova, M; Tuma, J; Skotakova, J; Cervinkova, I; Valik, D; Zdrazilova-Dubska, L; Noskova, H; Pal, K; Slaby, O; Fabian, P; Kozakova, S; Neradil, J; Veselska, R; Kanderova, V; Hrusak, O; Freiberger, T; Klement, GL; Sterba, J, 2020: Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside. FRONTIERS IN ONCOLOGY 9, doi: 10.3389/fonc.2019.01531
• Sklenicka, V; Kucharova, K; Svoboda, M; Kvapilova, M; Dvorak, J; Kra, P, 2020: Creep behaviour of unreinforced and reinforced QE22 magnesium alloy: A comparison. KOVOVE MATERIALY-METALLIC MATERIALS 58(2), p. 71 - 82, doi: 10.4149/km_2020_2_71
• Kozlova, V; Ledererova, A; Mancikova, V; Mayer, J; Pospisilova, S; Doubek, M; Smida, M, 2020: Elucidation of factors enhancing the expression of CD20 and thereby efficiency of CD20 monoclonal antibodies through epigenetic drug screening of resistant CLL cells. LEUKEMIA & LYMPHOMA 61, p. 256 - 257
• Komkov, A; Miroshnichenkova, A; Nugmanov, G; Popov, A; Pogorelyy, M; Zapletalova, E; Jelinkova, H; Pospisilova, S; Lebedev, Y; Chudakov, D; Olshanskaya, Y; Plevova, K; Maschan, M; Mamedov, I, 2020: High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies. BRITISH JOURNAL OF HAEMATOLOGY 188(5), p. 723 - 731, doi: 10.1111/bjh.16230
• Vrbovska, V; Sedlacek, I; Zeman, M; Svec, P; Kovarovic, V; Sedo, O; Laichmanova, M; Doskar, J; Pantucek, R, 2020: Characterization of Staphylococcus intermedius Group Isolates Associated with Animals from Antarctica and Emended Description of Staphylococcus delphini. MICROORGANISMS 8(2), doi: 10.3390/microorganisms8020204
• Condoluci, A; di Bergamo, LT; Langerbeins, P; Hoechstetter, MA; Herling, CD; De Paoli, L; Delgado, J; Rabe, KG; Gentile, M; Doubek, M; Mauro, FR; Chiodin, G; Mattsson, M; Bahlo, J; Cutrona, G; Kotaskova, J; Deambrogi, C; Smedby, KE; Spina, V; Bruscaggin, A; Wu, W; Moia, R; Bianchi, E; Gerber, B; Zucca, E; Gillessen, S; Ghielmini, M; Cavalli, F; Stussi, G; Hess, MA; Baumann, TS; Neri, A; Ferrarini, M; Rosenquist, R; Forconi, F; Foa, R; Pospisilova, S; Morabito, F; Stilgenbauer, S; Dohner, H; Parikh, SA; Wierda, WG; Montserrat, E; Gaidano, G; Hallek, M; Rossi, D, 2020: International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia. BLOOD 135(21), p. 1859 - 1869, doi: 10.1182/blood.2019003453
• Dvorakova, H; Leontovyc, R; Machacek, T; O´Donoghue, AJ; Sedo, O; Zdrahal, Z; Craik, CS; Caffrey, CR; Horak, P; Mikes, L, 2020: Isoforms of Cathepsin B1 in Neurotropic Schistosomula of Trichobilharzia regenti Differ in Substrate Preferences and a Highly Expressed Catalytically Inactive Paralog Binds Cystatin. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 10, doi: 10.3389/fcimb.2020.00066
• Malcikova, J; Pavlova, S; Vonkova, B; Kotaskova, J; Radova, L; Plevova, K; Zenatova, M; Hynst, J; Dvorackova, B; Panovska, A; Brychtova, Y; Tichy, B; Navrkalova, V; Pal, K; Mayer, J; Doubek, M; Pospisilova, S, 2020: Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact. LEUKEMIA & LYMPHOMA 61, p. 222 - 224
• Laidou, S; Alanis-Lobato, G; Pribyl, J; Rasko, T; Tichy, B; Mikulasek, K; Tsagiopoulou, M; Oppelt, J; Kastrinaki, G; Lefaki, M; Singh, M; Zink, A; Chondrogianni, N; Psomopoulos, F; Prigione, A; Ivics, Z; Pospisilova, S; Skladal, P; Izsvak, Z; Andrade-Navarro, MA; Petrakis, S, 2020: Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery. REDOX BIOLOGY 32, doi: 10.1016/j.redox.2020.101458
• Mancikova, V; Peschelova, H; Kozlova, V; Ledererova, A; Ladungova, A; Verner, J; Loja, T; Folber, F; Mayer, J; Pospisilova, S; Smida, M, 2020: Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia. JOURNAL FOR IMMUNOTHERAPY OF CANCER 8(1), doi: 10.1136/jitc-2019-000471
• Nemcova, L; Nekvindova, L; Spacek, M; Simkovic, M; Papajik, T; Brejcha, M; Lysak, D; Zuchnicka, J; Novak, J; Starostka, D; Poul, H; Vrbacky, F; Urbanova, R; Panovska, A; Plevova, K; Pospisilova, S; Hrobkova, S; Koritakova, E; Smolej, L; Doubek, M, 2020: Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus bendamustine, and rituximab plus chlorambucil in front-line CLL therapy: The GO-CLLEAR Study by Czech CLL Study Group. LEUKEMIA & LYMPHOMA 61, p. 57 - 59
• Radtanakatikanon, A; Keller, SM; Darzentas, N; Moore, PF; Folch, G; Ngoune, VN; Lefranc, MP; Vernau, W, 2020: Topology and expressed repertoire of the Felis catus T cell receptor loci. BMC GENOMICS 21(1), doi: 10.1186/s12864-019-6431-5
• Jaskova, Z; Pavlova, S; Malcikova, J; Brychtova, Y; Trbusek, M, 2020: PRIMA-1(MET) cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells. LEUKEMIA RESEARCH 89, doi: 10.1016/j.leukres.2019.106288
• Gojo, J; Pavelka, Z; Zapletalova, D; Schmook, MT; Mayr, L; Madlener, S; Kyr, M; Vejmelkova, K; Smrcka, M; Czech, T; Dorfer, C; Skotakova, J; Azizi, AA; Chocholous, M; Reisinger, D; Lastovicka, D; Valik, D; Haberler, C; Peyrl, A; Noskova, H; Pal, K; Jezova, M; Veselska, R; Kozakova, S; Slaby, O; Slavc, I; Sterba, J, 2020: Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities. FRONTIERS IN ONCOLOGY 9, doi: 10.3389/fonc.2019.01436
• Gokbuget, N; Dombret, H; Giebel, S; Bruggemann, M; Doubek, M; Foa, R; Hoelzer, D; Kim, C; Martinelli, G; Parovichnikova, E; Ribera, JM; Schoonen, M; Tuglus, C; Zugmaier, G; Bassan, R, 2020: Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia. EUROPEAN JOURNAL OF HAEMATOLOGY , doi: 10.1111/ejh.13375
• Brenna, E; Davydov, AN; Ladell, K; McLaren, JE; Bonaiuti, P; Metsger, M; Ramsden, JD; Gilbert, SC; Lambe, T; Price, DA; Campion, SL; Chudakov, DM; Borrow, P; McMichael, AJ, 2020: CD4(+) T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4(+) Cells. CELL REPORTS 30(1), p. 137 - +, doi: 10.1016/j.celrep.2019.12.016
• Maurer, B; Nivarthi, H; Wingelhofer, B; Pham, HTT; Schlederer, M; Suske, T; Grausenburger, R; Schiefer, AI; Prchal-Murphy, M; Chen, D; Winkler, S; Merkel, O; Kornauth, C; Hofbauer, M; Hochgatterer, B; Hoermann, G; Hoelbl-Kovacic, A; Prochazkova, J; Lobello, C; Cumaraswamy, AA; Latzka, J; Kitzwogerer, M; Chott, A; Janikova, A; Pospisilova, S; Loizou, JI; Kubicek, S; Valent, P; Kolbe, T; Grebien, F; Kenner, L; Gunning, PT; Kralovics, R; Herling, M; Muller, M; Rulicke, T; Sexl, V; Moriggl, R, 2020: High activation of STAT5A drives peripheral T-cell lymphoma and leukemia. HAEMATOLOGICA 105(2), p. 435 - 447, doi: 10.3324/haematol.2019.216986
• Romzova, M; Smitalova, D; Tom, N; Jurcek, T; Culen, M; Zackova, D; Mayer, J; Racil, Z, 2020: Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia. BRITISH JOURNAL OF HAEMATOLOGY , doi: 10.1111/bjh.16382
• Grimsholm, O; Mortari, EP; Davydov, AN; Shugay, M; Obraztsova, AS; Bocci, C; Marasco, E; Marcellini, V; Aranburu, A; Farroni, C; Silvestris, DA; Cristofoletti, C; Giorda, E; Scarsella, M; Cascioli, S; Barresi, S; Lougaris, V; Plebani, A; Cancrini, C; Finocchi, A; Moschese, V; Valentini, D; Vallone, C; Signore, F; de Vincentiis, G; Zaffina, S; Russo, G; Gallo, A; Locatelli, F; Tozzi, AE; Tartaglia, M; Chudakov, DM; Carsetti, R, 2020: The Interplay between CD27(dull) and CD27(brig)(ht) B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory. CELL REPORTS 30(9), p. 2963 - +, doi: 10.1016/j.celrep.2020.02.022

2019

• Baliakas, P; Jeromin, S; Iskas, M; Puiggros, A; Plevova, K; Nguyen-Khac, F; Davis, Z; Rigolin, GM; Visentin, A; Xochelli, A; Delgado, J; Baran-Marszak, F; Stalika, E; Abrisqueta, P; Durechova, K; Papaioannou, G; Eclache, V; Dimou, M; Iliakis, T; Collado, R; Doubek, M; Calasanz, MJ; Ruiz-Xiville, N; Moreno, C; Jarosova, M; Leeksma, AC; Panayiotidis, P; Podgornik, H; Cymbalista, F; Anagnostopoulos, A; Trentin, L; Stavroyianni, N; Davi, F; Ghia, P; Kater, AP; Cuneo, A; Pospisilova, S; Espinet, B; Athanasiadou, A; Oscier, D; Haferlach, C; Stamatopoulos, K, 2019: Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. BLOOD 133(11), p. 1205 - 1216, doi: 10.1182/blood-2018-09-873083
• Ruzicka, M; Soucek, R; Kulhanek, P; Radova, L; Fajkusova, L; Reblova, K, 2019: Bending of DNA duplexes with mutation motifs. DNA RESEARCH 26(4), p. 341 - 352, doi: 10.1093/dnares/dsz013
• Micenkova, L; Bosak, J; Kucera, J; Hrala, M; Dolejsova, T; Sedo, O; Linke, D; Fiser, R; Smajs, D, 2019: Colicin Z, a structurally and functionally novel colicin type that selectively kills enteroinvasive Escherichia coli and Shigella strains. SCIENTIFIC REPORTS 9, doi: 10.1038/s41598-019-47488-8
• Bereshchenko, O; Lo Re, O; Nikulenkov, F; Flamini, S; Kotaskova, J; Mazza, T; Le Pannerer, MM; Buschbeck, M; Giallongo, C; Palumbo, G; Li Volti, G; Pazienza, V; Cervinek, L; Riccardi, C; Krejci, L; Pospisilova, S; Stewart, AF; Vinciguerra, M, 2019: Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome. CLINICAL EPIGENETICS 11(1), doi: 10.1186/s13148-019-0724-z
• Mortari, EP; Grimsholm, O; Davydov, A; Shugay, M; Gallo, A; Locatelli, F; Tartaglia, M; Chudakov, DM; Carsetti, R, 2019: Distinct subsets of human memory B cells define the strategy of the human memory response throughout life. EUROPEAN JOURNAL OF IMMUNOLOGY 49, p. 713 - 714
• Vecera, M; Oppelt, J; Radova, L; Lipina, R; Reguli, S; Smrcka, M; Jancalek, R; Filip, M; Hermanova, M; Kren, L; Sana, J; Kopkova, A; Kovacova, J; Slaby, O, 2019: Dysregulated expression of lncRNAs in glioblastoma multiforme and their association with overall survival. CANCER RESEARCH 79(13), doi: 10.1158/1538-7445.AM2019-3575
• Fazio, G; Massa, V; Grioni, A; Bystry, V; Rigamonti, S; Saitta, C; Galbiati, M; Rizzari, C; Consarino, C; Biondi, A; Selicorni, A; Cazzaniga, G, 2019: First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia. JOURNAL OF CLINICAL PATHOLOGY 72(8), p. 558 - 561, doi: 10.1136/jclinpath-2019-205707
• Sedlacek, I; Pantucek, R; Holochova, P; Kralova, S; Stankova, E; Vrbovska, V; Sedo, O; Svec, P; Busse, HJ, 2019: Hymenobacter humicola sp. nov., isolated from soils in Antarctica. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY 69(9), p. 2755 - 2761, doi: 10.1099/ijsem.0.003555
• Taus, P; Plevova, K; Darzentas, N; Pal, K; Pospisilova, S, 2019: Identification of novel chronic lymphocytic leukemia subtypes using pathway mutation scores and consensus clustering. EUROPEAN JOURNAL OF HUMAN GENETICS 27, p. 1553 - 1554
• Gorska, A; Gruchala-Niedoszytko, M; Lange, M; Niedoszytko, M; Valent, P; Brockow, K; Gotlib, J; Triggiani, M; Sperr, WR; Elberink, HO; Hartmann, K; Gleixner, KV; Bonifacio, M; Bonadonna, P; Zanotti, R; Arock, M; Hermine, O; Sabato, V; Aberer, E; Van Anrooij, B; Reiter, A; Doubek, M, 2019: Impact of the body mass index in patients with mastocytosis. ALLERGY 74, p. 424 - 425
• Condoluci, A; di Bergamo, LT; Langerbeins, P; Hoechstetter, M; Herling, C; De Paoli, L; Delgado, J; Rabe, KG; Gentile, M; Doubek, M; Mauro, FR; Chiodin, G; Mattsson, M; Bahlo, J; Cutrona, G; Kotaskova, J; Deambrogi, C; Spina, V; Bruscaggin, A; Moia, R; Bianchi, E; Gerber, B; Zucca, E; Ghielmini, M; Cavalli, F; Stussi, G; Neri, A; Ferrarini, M; Rosenquist, R; Forconi, F; Foa, R; Pospisilova, S; Morabito, F; Parikh, SA; Wierda, WG; Montserrat, E; Gaidano, G; Hallek, M; Rossi, D, 2019: International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 19, p. S278 - S278, doi: 10.1016/j.clml.2019.07.212
• Gregorova, J; Radova, L; Gablo, NA; Almasi, M; Stork, M; Slaby, O; Pour, L; Minarik, J; Sevcikova, S, 2019: MicroRNA analysis in multiple myeloma and extramedullary disease. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 19(10), p. E65 - E66, doi: 10.1016/j.clml.2019.09.103
• Vonkova, B; Blabakova, I; Hruban, L; Janku, P; Pospisilova, S, 2019: MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia. BIOMEDICAL PAPERS-OLOMOUC 163(3), p. 259 - 264, doi: 10.5507/bp.2018.075
• Kovacova, J; Juracek, J; Poprach, A; Kopecky, J; Fiala, O; Svoboda, M; Fabian, P; Radova, L; Brabec, P; Buchler, T; Slaby, O, 2019: MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients. CANCER GENOMICS & PROTEOMICS 16(5), p. 353 - 359, doi: 10.21873/cgp.20140
• Krafcikova, M; Dzatko, S; Caron, C; Granzhan, A; Fiala, R; Loja, T; Teulade-Fichou, MP; Fessl, T; Hansel-Hertsch, R; Mergny, JL; Foldynova-Trantirkova, S; Trantirek, L, 2019: Monitoring DNA-Ligand Interactions in Living Human Cells Using NMR Spectroscopy. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 141(34), p. 13281 - 13285, doi: 10.1021/jacs.9b03031
• Scheijen, B; Meijers, RWJ; Rijntjes, J; van der Klift, MY; Mobs, M; Steinhilber, J; Reigl, T; van den Brand, M; Kotrova, M; Ritter, JM; Catherwood, MA; Stamatopoulos, K; Bruggemann, M; Davi, F; Darzentas, N; Pott, C; Fend, F; Hummel, M; Langerak, AW; Groenen, PJTA, 2019: Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS. LEUKEMIA 33(9), p. 2227 - 2240, doi: 10.1038/s41375-019-0508-7
• van Bladel, D; van den Brand, M; Rijntjes, J; Brinkman, A; Reigl, T; Darzentas, N; Hess, C; Hebeda, K; Groenen, P; van Krieken, H; Scheijen, B, 2019: Next-generation sequencing-based clonality assessment of immunoglobulin gene rearrangements distinguishes relapse from second primary classical Hodgkin lymphoma. VIRCHOWS ARCHIV 475, p. S118 - S118
• Lebedin, M; Perez, MF; Davydov, A; Khorkova, S; Chudakov, D; Lanzavecchia, A; de la Rosa, K, 2019: Antibody diversification through non-VDJ insertions. EUROPEAN JOURNAL OF IMMUNOLOGY 49, p. 8 - 8
• Vaska, A; Makohusova, M; Plevova, K; Hikkel, I; Cermak, M; Skalicka, K; Chovanec, F; Fabri, O; Kolenova, A, 2019: Analysis of Genetic Prognostic Markers of Pediatric B-Acute Lymphoblastic Leukemia in Slovak Population. PEDIATRIC BLOOD & CANCER 66, p. S256 - S257
• Pospisilova, S; Marvanova, P; Treml, J; Moricz, AM; Ott, PG; Mokry, P; Odehnalova, K; Sedo, O; Cizek, A; Jampilek, J, 2019: Activity of N-Phenylpiperazine Derivatives Against Bacterial and Fungal Pathogens. CURRENT PROTEIN & PEPTIDE SCIENCE 20(11), p. 1119 - 1129, doi: 10.2174/1389203720666190913114041
• Moysiadis, T; Baliakas, P; Rossi, D; Catherwood, M; Strefford, JC; Delgado, J; Anagnostopoulos, A; Belessi, C; Stavroyianni, N; Pospisilova, S; Oscier, D; Gaidano, G; Campo, E; Rosenquist, R; Ghia, P; Stamatopoulos, K, 2019: Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors. LEUKEMIA 33(7), p. 1801 - 1805, doi: 10.1038/s41375-018-0322-7
• Obrucova, H; Kotaskova, I; Tihelkova, R; Hola, V; Ruzicka, F; Freiberger, T, 2019: Fluorescent Capillary Electrophoresis Is Superior to Culture in Detecting Candida Species from Samples of Urinary Catheters and Ureteral Stents with Mono- or Polyfungal Biofilm Growth. JOURNAL OF CLINICAL MICROBIOLOGY 57(4), doi: 10.1128/JCM.01861-18
• Spunarova, M; Tom, N; Pavlova, S; Mraz, M; Brychtova, Y; Doubek, M; Panovska, A; Francova, HS; Brzobohata, A; Pospisilova, S; Mayer, J; Trbusek, M, 2019: Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. LEUKEMIA RESEARCH 81, p. 75 - 81, doi: 10.1016/j.leukres.2019.04.015
• Kotaskova, I; Obrucova, H; Malisova, B; Videnska, P; Zwinsova, B; Peroutkova, T; Dvorackova, M; Kumstat, P; Trojan, P; Ruzicka, F; Hola, V; Freiberger, T, 2019: Molecular Techniques Complement Culture-Based Assessment of Bacteria Composition in Mixed Biofilms of Urinary Tract Catheter-Related Samples. FRONTIERS IN MICROBIOLOGY 10, doi: 10.3389/fmicb.2019.00462
• Grymova, T; Vlkova, M; Soucek, P; Hakl, R; Nechvatalova, J; Slanina, P; Stichova, J; Litzman, J; Freiberger, T, 2019: Neutrophils Are Dysregulated in Patients with Hereditary Angioedema Types I and II in a Symptom-Free Period. MEDIATORS OF INFLAMMATION , doi: 10.1155/2019/9515628
• Folta, A; Culen, M; Jeziskova, I; Herudkova, Z; Tom, N; Hlubinkova, T; Janeckova, V; Durinikova, A; Vydra, J; Semerad, L; Dvorakova, D; Remesova, H; Cerovska, E; Cetkovsky, P; Jindra, P; Szotkowski, T; Zak, P; Mayer, J; Racil, Z, 2019: Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients. BRITISH JOURNAL OF HAEMATOLOGY 186(2), p. 300 - 310, doi: 10.1111/bjh.15916
• Fiedorova, K; Radvansky, M; Nemcova, E; Grombirikova, H; Bosak, J; Cernochova, M; Lexa, M; Smajs, D; Freiberger, T, 2019: The Impact of DNA Extraction Methods on Stool Bacterial and Fungal Microbiota Community Recovery. FRONTIERS IN MICROBIOLOGY 10, doi: 10.3389/fmicb.2019.00821
• Kozubik, KS; Trizuljak, J; Peova, M; Pal, K; Reblova, K; Radova, L; Pospiilova; Doubek, M, 2019: A novel germline mutation in GP1BA gene in family with hereditary macrothrombocytopenia. EUROPEAN JOURNAL OF HUMAN GENETICS 27, p. 208 - 208
• Trizuljak, J; Doubkova, M; Hrazdirova, A; Vrzalova, Z; Blahakova, I; Radova, L; Pospisilova, S; Doubek, M, 2019: A rare diagnosis: Hermansky-Pudlak syndrome in a patient with pulmonary fibrosis, oculocutaneous albinism and thrombocytopathy. EUROPEAN JOURNAL OF HUMAN GENETICS 27, p. 1252 - 1252
• Doubkova, M; Trizuljak, J; Vrzalova, Z; Hrazdirova, A; Blahakova, I; Radova, L; Pospisilova, S; Doubek, M, 2019: Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report. BMC PULMONARY MEDICINE 19(1), doi: 10.1186/s12890-019-0941-4
• Knecht, H; Reigl, T; Kotrova, M; Appelt, F; Stewart, P; Bystry, V; Krejci, A; Grioni, A; Pal, K; Stranska, K; Plevova, K; Rijntjes, J; Songia, S; Svaton, M; Fronkova, E; Bartram, J; Scheijen, B; Herrmann, D; Garcia-Sanz, R; Hancock, J; Moppett, J; van Dongen, JJM; Cazzaniga, G; Davi, F; Groenen, PJTA; Hummel, M; Macintyre, EA; Stamatopoulos, K; Trka, J; Langerak, AW; Gonzalez, D; Pott, C; Bruggemann, M; Darzentas, N, 2019: Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS. LEUKEMIA 33(9), p. 2254 - 2265, doi: 10.1038/s41375-019-0499-4
• Egle, A; Melchardt, T; Obrtlikova, P; Smolej, L; Kozak, T; Steurer, M; Andel, J; Burgstaller, S; Mikuskova, E; Gercheva, L; Nosslinger, T; Papapjik, T; Ladicka, M; Girschikofsky, M; Hrubisko, M; Jager, U; Voskova, D; Pecherstorfer, M; Kralikova, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochova, E; Palasthy, S; Stehlikova, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R, 2019: Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. CANCER MEDICINE 8(4), p. 1401 - 1405, doi: 10.1002/cam4.1980
• Bruggemann, M; Kotrova, M; Knecht, H; Bartram, J; Boudjogrha, M; Bystry, V; Fazio, G; Fronkova, E; Giraud, M; Grioni, A; Hancock, J; Herrmann, D; Jimenez, C; Krejci, A; Moppett, J; Reigl, T; Salson, M; Scheijen, B; Schwarz, M; Songia, S; Svaton, M; van Dongen, JJM; Villarese, P; Wakeman, S; Wright, G; Cazzaniga, G; Davi, F; Garcia-Sanz, R; Gonzalez, D; Groenen, PJTA; Hummel, M; Macintyre, EA; Stamatopoulos, K; Pott, C; Trka, J; Darzentas, N; Langerak, AW, 2019: Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study. LEUKEMIA 33(9), p. 2241 - 2253, doi: 10.1038/s41375-019-0496-7
• Jarosov?, M; Plevov?, K; Kotaskov?, J; Doubek, M; Posp?silov?, S, 2019: The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature. LEUKEMIA & LYMPHOMA 60(10), p. 2348 - 2355, doi: 10.1080/10428194.2019.1576038
• Muggen, AF; de Jong, M; Wolvers-Tettero, ILM; Kallemeijn, MJ; Teodosio, C; Darzentas, N; Stadhouders, R; Ijspeert, H; van der Burg, M; van Ijcken, WFJ; Verhaar, JAN; Abdulahad, WH; Brouwer, E; Boots, AMH; Hendriks, RW; van Dongen, JJM; Langerak, AW, 2019: The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age. IMMUNITY & AGEING 16(1), doi: 10.1186/s12979-019-0163-x
• Grioni, A; Fazio, G; Rigamonti, S; Bystry, V; Daniele, G; Dostalova, Z; Quadri, M; Saitta, C; Silvestri, D; Songia, S; Storlazzi, CT; Biondi, A; Darzentas, N; Cazzaniga, G, 2019: A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B-cell Acute Lymphoblastic Leukemia. HEMASPHERE 3(3), doi: 10.1097/HS9.0000000000000250
• Kopkova, A; Sana, J; Machackova, T; Vecera, M; Radova, L; Trachtova, K; Vybihal, V; Smrcka, M; Kazda, T; Slaby, O; Fadrus, P, 2019: Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors. CANCERS 11(10), doi: 10.3390/cancers11101546
• Vaska, A; Makohusova, M; Plevova, K; Skalicka, K; Cermak, M; Chovanec, F; Fabri, O; Svec, P; Kolenova, A, 2019: Clinical impact of genomic analysis in children with B-acute lymphoblastic leukemia: A pilot study in Slovakia. NEOPLASMA 66(6), p. 1009 - 1018, doi: 10.4149/neo_2019_190328N274
• Herudkova, Z; Culen, M; Folta, A; Jeziskova, I; Cerna, J; Loja, T; Tom, N; Smejkal, J; Semerad, L; Dvorakova, D; Mayer, J; Racil, Z, 2019: Clonal hierarchy of main molecular lesions in acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , doi: 10.1111/bjh.16341
• Noskova, H; Adamcova, S; Knoflickova, D; Pal, K; Grioni, A; Hornakova, T; Merta, T; Mudry, P; Pavelka, Z; Vejmelkova, K; Sterba, J; Slaby, O, 2019: Comparison of whole exome sequencing and FoundationOne Heme sequencing panel as tools for precision oncology in paediatric patients with difficult-to-treat solid tumours. ANNALS OF ONCOLOGY 30, doi: 10.1093/annonc/mdz413.102
• Matsuyama, A; Bienzle, D; Richardson, D; Deravi, N; Hwang, MH; Darzentas, N; Keller, SM, 2019: Composite lymphoma of concurrent T zone lymphoma and large cell B cell lymphoma in a dog. BMC VETERINARY RESEARCH 15(1), doi: 10.1186/s12917-019-2154-8
• Sperr, WR; Kundi, M; Alvarez-Twose, I; van Anrooij, B; Elberink, JNGO; Gorska, A; Niedoszytko, M; Gleixner, KV; Hadzijusufovic, E; Zanotti, R; Bonadonna, P; Bonifacio, M; Perkins, C; Illerhaus, A; Elena, C; Merante, S; Shoumariyeh, K; von Bubnoff, N; Parente, R; Jawhar, M; Fortina, AB; Caroppo, F; Brockow, K; Zink, A; Fuchs, D; Kilbertus, AJ; Yavuz, AS; Doubek, M; Hagglund, H; Panse, J; Sabato, V; Bretterklieber, A; Niederwieser, D; Breynaert, C; Hartmann, K; Triggiani, M; Nedoszytko, B; Reiter, A; Orfao, A; Hermine, O; Gotlib, J; Arock, M; Kluin-Nelemans, HC; Valent, P, 2019: International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study. LANCET HAEMATOLOGY 6(12), p. E638 - E649, doi: 10.1016/S2352-3026(19)30166-8
• Salles, G; Bachy, E; Smolej, L; Simkovic, M; Baseggio, L; Panovska, A; Besson, H; Healy, N; Garside, J; Iraqi, W; Diels, J; Pick-Lauer, C; Spacek, M; Urbanova, R; Lysak, D; Hermans, R; Lundbom, J; Callet-Bauchu, E; Doubek, M, 2019: Single-agent ibrutinib in RESONATE-2 (TM) and RESONATE (TM) versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia. ANNALS OF HEMATOLOGY 98(12), p. 2749 - 2760, doi: 10.1007/s00277-019-03830-8
• Hynst, J; Plevova, K; Radova, L; Bystry, V; Pali, K; Pospisilova, S, 2019: Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants. PEERJ 7, doi: 10.7717/peerj.7071
• Xochelli, A; Bikos, V; Polychronidou, E; Galigalidou, C; Agathangelidis, A; Charlotte, F; Moschonas, P; Davis, Z; Colombo, M; Roumelioti, M; Sutton, LA; Groenen, P; van den Brand, M; Boudjoghra, M; Algara, P; Traverse-Glehen, A; Ferrer, A; Stalika, E; Karypidou, M; Kanellis, G; Kalpadakis, C; Mollejo, M; Pangalis, G; Vlamos, P; Amini, RM; Pospisilova, S; Gonzalez, D; Ponzoni, M; Anagnostopoulos, A; Giudicelli, V; Lefranc, MP; Espinet, B; Panagiotidis, P; Piris, MA; Du, MQ; Rosenquist, R; Papadaki, T; Belessi, C; Ferrarini, M; Oscier, D; Tzovaras, D; Ghia, P; Davi, F; Hadzidimitriou, A; Stamatopoulos, K, 2019: Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations. JOURNAL OF PATHOLOGY 247(4), p. 416 - 421, doi: 10.1002/path.5209
• Kanderova, V; Grombirikova, H; Zentsova, I; Reblova, K; Klocperk, A; Fejtkova, M; Bloomfield, M; Ravcukova, B; Kalina, T; Freiberger, T; Sediva, A, 2019: Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8. HAEMATOLOGICA 104(1), p. E32 - E34, doi: 10.3324/haematol.2018.201673
• Vlkova, M; Chovancova, Z; Nechvatalova, J; Connelly, AN; Davis, MD; Slanina, P; Travnickova, L; Litzman, M; Grymova, T; Soucek, P; Freiberger, T; Litzman, J; Hel, Z, 2019: Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders. JOURNAL OF IMMUNOLOGY 202(1), p. 93 - 104, doi: 10.4049/jimmunol.1800102
• Baliakas, P; Moysiadis, T; Hadzidimitriou, A; Xochelli, A; Jeromin, S; Agathangelidis, A; Mattsson, M; Sutton, LA; Minga, E; Scarfo, L; Rossi, D; Davis, Z; Villamor, N; Parker, H; Kotaskova, J; Stalika, E; Plevova, K; Mansouri, L; Cortese, D; Navarro, A; Delgado, J; Larrayoz, M; Young, E; Anagnostopoulos, A; Smedby, KE; Juliusson, G; Sheehy, O; Catherwood, M; Strefford, JC; Stavroyianni, N; Belessi, C; Pospisilova, S; Oscier, D; Gaidano, G; Campo, E; Haferlach, C; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2019: Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia. HAEMATOLOGICA 104(2), p. 360 - 369, doi: 10.3324/haematol.2018.195032
• Olbertova, H; Plevova, K; Stranska, K; Pospisilova, S, 2019: Telomere dynamics in adult hematological malignancies. BIOMEDICAL PAPERS-OLOMOUC 163(1), p. 1 - 7, doi: 10.5507/bp.2018.084
• Doubkova, M; Kozubik, KS; Radova, L; Pesova, M; Trizuljak, J; Pal, K; Svobodova, K; Reblova, K; Svozilova, H; Vrzalova, Z; Pospisilova, S; Doubek, M, 2019: A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia. HUMAN GENOME VARIATION 6, doi: 10.1038/s41439-019-0044-z
• Hernandez-Sanchez, M; Kotaskova, J; Rodriguez, AE; Radova, L; Tamborero, D; Abaigar, M; Plevova, K; Benito, R; Tom, N; Quijada-Alamo, M; Bikos, V; Martin, AA; Pal, K; de Coca, AG; Doubek, M; Lopez-Bigas, N; Hernandez-Rivas, JM; Pospisilova, S, 2019: CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase. LEUKEMIA 33(2), p. 518 - 522, doi: 10.1038/s41375-018-0255-1
• Zaprazna, K; Reblova, K; Svobodova, V; Radova, L; Bystry, V; Baloun, J; Durechova, K; Tom, N; Loja, T; Buresova, M; Stranska, K; Oltova, A; Doubek, M; Atchison, ML; Trbusek, M; Malcikova, J; Pospisilova, S, 2019: Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia. ANNALS OF HEMATOLOGY 98(2), p. 423 - 435, doi: 10.1007/s00277-018-3520-5
• Mareckova, A; Malcikova, J; Tom, N; Pal, K; Radova, L; Salek, D; Janikova, A; Moulis, M; Smardova, J; Kren, L; Mayer, J; Trbusek, M, 2019: ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. LEUKEMIA & LYMPHOMA 60(6), p. 1420 - 1428, doi: 10.1080/10428194.2018.1542144

2018

• Brazdilova, K; Plevova, K; Francova, HS; Kockova, H; Borsky, M; Bikos, V; Malcikova, J; Oltova, A; Kotaskova, J; Tichy, B; Brychtova, Y; Mayer, J; Doubek, M; Pospisilova, S, 2018: Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL. LEUKEMIA 32(1), p. 234 - 236, doi: 10.1038/leu.2017.274
• Iacocca, MA; Chora, JR; Carrie, A; Freiberger, T; Leigh, SE; Defesche, JC; Kurtz, CL; DiStefano, MT; Santos, RD; Humphries, SE; Mata, P; Jannes, CE; Hooper, AJ; Wilemon, KA; Benlian, P; O´Connor, R; Garcia, J; Wand, H; Tichy, L; Sijbrands, EJ; Hegele, RA; Bourbon, M; Knowles, JW, 2018: ClinVar database of global familial hypercholesterolemia-associated DNA variants. HUMAN MUTATION 39(11), p. 1631 - 1640, doi: 10.1002/humu.23634
• Pavlasova, G; Borsky, M; Svobodova, V; Oppelt, J; Cerna, K; Novotna, J; Seda, V; Fojtova, M; Fajkus, J; Brychtova, Y; Doubek, M; Pospisilova, S; Mayer, J; Mraz, M, 2018: Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. LEUKEMIA 32(9), p. 2028 - 2031, doi: 10.1038/s41375-018-0211-0
• Hwang, MH; Darzentas, N; Bienzle, D; Moore, PF; Morrison, J; Keller, SM, 2018: Characterization of the canine immunoglobulin heavy chain repertoire by next generation sequencing. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 202, p. 181 - 190, doi: 10.1016/j.vetimm.2018.07.002
• Vrzalova, Z; Jelinkova, H; Hrabovsky, S; Folber, F; Salek, C; Horacek, J; Zaliova, M; Stika, J; Slavikova, M; Pospisilova, S; Doubek, M, 2018: Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic. BLOOD 132, doi: 10.1182/blood-2018-99-118308
• Kotrova, M; Szczepanowski, M; Knecht, H; Faul, C; Kondakci, M; Steffen, B; Viardot, A; Kneba, M; Hoelzer, D; Goekbuget, N; Darzentas, N; Bruggemann, M, 2018: Monitoring of the Clonal Architecture of B-Cell Precursor ALL during Induction Chemoimmunotherapy. BLOOD 132, doi: 10.1182/blood-2018-99-112844
• Culen, M; Kosarova, Z; Jeziskova, I; Folta, A; Tom, N; Venglar, O; Dvorakova, D; Mayer, J; Racil, Z, 2018: Persistence of Mutations during Remission in 114 AML Patients. BLOOD 132, doi: 10.1182/blood-2018-99-110586
• Kotrova, M; Knecht, H; Herrmann, D; Schwarz, M; Olsen, K; Trautmann, H; Goekbuget, N; Pott, C; Darzentas, N; Bruggemann, M, 2018: The IG/TR Next Generation Marker Screening Developed within Euroclonality-NGS Consortium Is Successful in 94% of Acute Lymphoblastic Leukemia Samples. BLOOD 132, doi: 10.1182/blood-2018-99-112828
• Polychronidou, E; Kalamaras, I; Agathangelidis, A; Sutton, LA; Yan, XJ; Bikos, V; Vardi, A; Mochament, K; Chiorazzi, N; Belessi, C; Rosenquist, R; Ghia, P; Stamatopoulos, K; Vlamos, P; Chailyan, A; Overby, N; Marcatili, P; Hatzidimitriou, A; Tzovaras, D, 2018: Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia. BMC BIOINFORMATICS 19, doi: 10.1186/s12859-018-2381-1
• Spackova, N; Reblova, K, 2018: Role of Inosine-Uracil Base Pairs in the Canonical RNA Duplexes. GENES 9(7), doi: 10.3390/genes9070324
• Hrabovsky, S; Folber, F; Horacek, JM; Stehlikova, O; Jelinkova, H; Salek, C; Doubek, M, 2018: Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 18(11), p. 743 - 748, doi: 10.1016/j.clml.2018.06.030
• Kozubik, KS; Radova, L; Pesova, M; Reblova, K; Trizuljak, J; Plevova, K; Fiamoli, V; Gumulec, J; Urbankova, H; Szotkowski, T; Mayer, J; Pospisilova, S; Doubek, M, 2018: C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies. INTERNATIONAL JOURNAL OF HEMATOLOGY 108(6), p. 652 - 657, doi: 10.1007/s12185-018-2514-3
• Campo, E; Cymbalista, F; Ghia, P; Jager, U; Pospisilova, S; Rosenquist, R; Schuh, A; Stilgenbauer, S, 2018: TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics. HAEMATOLOGICA 103(12), p. 1956 - 1968, doi: 10.3324/haematol.2018.187583
• Plesingerova, H; Janovska, P; Mishra, A; Smyckova, L; Poppova, L; Libra, A; Plevova, K; Ovesna, P; Radova, L; Doubek, M; Pavlova, S; Pospisilova, S; Bryja, V, 2018: Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia. HAEMATOLOGICA 103(2), p. 313 - 324, doi: 10.3324/haematol.2017.178699
• Janovska, P; Verner, J; Kohoutek, J; Bryjova, L; Gregorova, M; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Ovesna, P; Blanarova, OV; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Egle, A; Pavlova, S; Poppova, L; Plevova, K; Pospisilova, S; Bryja, V, 2018: Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. BLOOD 131(11), p. 1206 - 1218, doi: 10.1182/blood-2017-05-786947
• Malcikova, J; Tausch, E; Rossi, D; Sutton, LA; Soussi, T; Zenz, T; Kater, AP; Niemann, CU; Gonzalez, D; Davi, F; Diaz, MG; Moreno, C; Gaidano, G; Stamatopoulos, K; Rosenquist, R; Stilgenbauer, S; Ghia, P; Pospisilova, S, 2018: ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. LEUKEMIA 32(5), p. 1070 - 1080, doi: 10.1038/s41375-017-0007-7
• Reblova, M; Miller, AN; Reblova, K; Stepanek, V, 2018: Phylogenetic classification and generic delineation of Calyptosphaeria gen. nov., Lentomitella, Spadicoides and Torrentispora (Sordariomycetes). STUDIES IN MYCOLOGY (89), p. 1 - 62, doi: 10.1016/j.simyco.2017.11.004
• Tikkanen, T; Leroy, B; Fournier, JL; Risques, RA; Malcikova, J; Soussi, T, 2018: Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing. HUMAN MUTATION 39(7), p. 925 - 933, doi: 10.1002/humu.23543
• Culen, M; Kosarova, Z; Jeziskova, I; Folta, A; Chovancova, J; Loja, T; Tom, N; Bystry, V; Janeckova, V; Dvorakova, D; Mayer, J; Racil, Z, 2018: The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 144(7), p. 1239 - 1251, doi: 10.1007/s00432-018-2652-2
• Lobello, C; Bikos, V; Janikova, A; Pospisilova, S, 2018: The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability. CANCERS 10(3), doi: 10.3390/cancers10030064
• Kubesova, B; Pavlova, S; Malcikova, J; Kabathova, J; Radova, L; Tom, N; Tichy, B; Plevova, K; Kantorova, B; Fiedorova, K; Slavikova, M; Bystry, V; Kissova, J; Gisslinger, B; Gisslinger, H; Penka, M; Mayer, J; Kralovics, R; Pospisilova, S; Doubek, M, 2018: Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status. LEUKEMIA 32(2), p. 450 - 461, doi: 10.1038/leu.2017.230
• Rawstron, AC; Kreuzer, KA; Soosapilla, A; Spacek, M; Stehlikova, O; Gambell, P; McIver-Brown, N; Villamor, N; Psarra, K; Arroz, M; Milani, R; de la Serna, J; Cedena, MT; Jaksic, O; Nomdedeu, J; Moreno, C; Rigolin, GM; Cuneo, A; Johansen, P; Johnsen, HE; Rosenquist, R; Niemann, CU; Kern, W; Westerman, D; Trneny, M; Mulligan, S; Doubek, M; Pospisilova, S; Hillmen, P; Oscier, D; Hallek, M; Ghia, P; Montserrat, E, 2018: Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. CYTOMETRY PART B-CLINICAL CYTOMETRY 94(1900-01-01T00:00:00.000), p. 121 - 128, doi: 10.1002/cyto.b.21595
• Zaprazna, K; Basu, A; Tom, N; Jha, V; Hodawadekar, S; Radova, L; Malcikova, J; Tichy, B; Pospisilova, S; Atchison, ML, 2018: Transcription factor YY1 can control AID-mediated mutagenesis in mice. EUROPEAN JOURNAL OF IMMUNOLOGY 48(2), p. 273 - 282, doi: 10.1002/eji.201747065
• Baliakas, P.; Mattsson, M.; Hadzidimitriou, A.; Minga, E.; Agathangelidis, A.; Sutton, L.; Scarfo, L.; Davis, Z.; Yan, X.; Plevova, K.; Sandberg, Y.; Vojdeman, F. J.; Tzenou, T.; Chu, C. C.; Veronese, S.; Mansouri, L.; Smedby, K. E.; Giudicelli, V.; Nguyen-Khac, F.; Panagiotidis, P.; Juliusson, G.; Anagnostopoulos, A.; Lefranc, M.; Trentin, L.; Catherwood, M.; Montillo, M.; Niemann, C. U.; Langerak, A. W.; Pospisilova, S.; Stavroyianni, N.; Chiorazzi, N.; Oscier, D.; Jelinek, D. F.; Shanafelt, T.; Darzentas, N.; Belessi, C.; Davi, F.; Ghia, P.; Rosenquist, R.; Stamatopoulos, K., 2018: No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. HAEMATOLOGICA , doi: 10.3324/haematol.2017.182634
• Tom, N; Tom, O; Malcikova, J; Pavlova, S; Kubesova, B; Rausch, T; Kolarik, M; Benes, V; Bystry, V; Pospisilova, S, 2018: ToTem: a tool for variant calling pipeline optimization. BMC BIOINFORMATICS 19, doi: 10.1186/s12859-018-2227-x

2017

• Drsata, T; Reblova, K; Besseova, I; Sponer, J; Lankas, F, 2017: rRNA C-Loops: Mechanical Properties of a Recurrent Structural Motif. JOURNAL OF CHEMICAL THEORY AND COMPUTATION 13(7), p. 3359 - 3371, doi: 10.1021/acs.jctc.7b00061
• Grodecka, L; Hujova, P; Kramarek, M; Krsjakova, T; Kovacova, T; Vondraskova, K; Ravcukova, B; Hrncirova, K; Soucek, P; Freiberger, T, 2017: Systematic analysis of splicing defects in selected primary immunodeficiencies-related genes. CLINICAL IMMUNOLOGY 180, p. 33 - 44, doi: 10.1016/j.clim.2017.03.010
• Leroy, B; Ballinger, ML; Baran-Marszak, F; Bond, GL; Braithwaite, A; Concin, N; Donehower, LA; El-Deiry, WS; Fenaux, P; Gaidano, G; Langerod, A; Hellstrom-Lindberg, E; Iggo, R; Lehmann-Che, J; Mai, PL; Malkin, D; Moll, UM; Myers, JN; Nichols, KE; Pospisilova, S; Ashton-Prolla, P; Rossi, D; Savage, SA; Strong, LC; Tonin, PN; Zeillinger, R; Zenz, T; Fraumeni, JF; Taschner, PEM; Hainaut, P; Soussi, T, 2017: Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. CANCER RESEARCH 77(6), p. 1250 - 1260, doi: 10.1158/0008-5472.CAN-16-2179
• Vavrova, E; Kantorova, B; Vonkova, B; Kabathova, J; Skuhrova-Francova, H; Diviskova, E; Letocha, O; Kotaskova, J; Brychtova, Y; Doubek, M; Mayer, J; Pospisilova, S, 2017: Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia. LEUKEMIA RESEARCH 60, p. 145 - 150, doi: 10.1016/j.leukres.2017.08.001
• Jeziskova, I; Semerad, L; Dvorakova, D; Janeckova, V; Culen, M; Kunetkova, T; Mayer, J; Racil, Z, 2017: Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia. LEUKEMIA & LYMPHOMA 58(3), p. 746 - 748, doi: 10.1080/10428194.2016.1213832
• Stehlikova, K; Skalova, D; Zidkova, J; Haberlova, J; Vohanka, S; Mazanec, R; Mrazova, L; Vondracek, P; Oslejskova, H; Zamecnik, J; Honzik, T; Zeman, J; Magner, M; Siskova, D; Langova, M; Gregor, V; Godava, M; Smolka, V; Fajkusova, L, 2017: Muscular dystrophies and myopathies: the spectrum of mutated genes in the Czech Republic. CLINICAL GENETICS 91(3), p. 463 - 469, doi: 10.1111/cge.12839
• Tichy, L; Fajkusova, L; Zapletalova, P; Schwarzova, L; Vrablik, M; Freiberger, T, 2017: Molecular Genetic Background of an Autosomal Dominant Hypercholesterolemia in the Czech Republic. PHYSIOLOGICAL RESEARCH 66, p. S47 - S54
• Kafkova, LR; Navrkalova, V; Jarosova, M; Loja, T; Chovancova, J; Kucerova, J; Kriegova, E; Prochazka, V; Novak, Z; Simkova, D; Pospisilova, S; Divoky, V, 2017: Ability to downregulate the level of cyclin-dependent kinase inhibitor p27(Kip1) after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway. LEUKEMIA & LYMPHOMA 58(1), p. 199 - 203, doi: 10.1080/10428194.2016.1187276
• Plesingerova, H; Librova, Z; Plevova, K; Libra, A; Tichy, B; Francova, HS; Vrbacky, F; Smolej, L; Mayer, J; Bryja, V; Doubek, M; Pospisilova, S, 2017: COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status. LEUKEMIA & LYMPHOMA 58(1), p. 70 - 79, doi: 10.1080/10428194.2016.1180690
• Bousios, A; Gaut, BS; Darzentas, N, 2017: Considerations and complications of mapping small RNA high-throughput data to transposable elements. MOBILE DNA 8, doi: 10.1186/s13100-017-0086-z
• Grodecka, L; Kovacova, T; Kramarek, M; Seneca, S; Stouffs, K; De Laet, C; Majer, F; Krsjakova, T; Hujova, P; Hrncirova, K; Soucek, P; Lissens, W; Buratti, E; Freiberger, T, 2017: Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation. JOURNAL OF MOLECULAR MEDICINE-JMM 95(3), p. 299 - 309, doi: 10.1007/s00109-016-1484-2
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Luft, T; Ho, AD; Kneba, M; Dreger, P, 2017: GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses. BONE MARROW TRANSPLANTATION 52(4), p. 544 - 551, doi: 10.1038/bmt.2016.305
• Langerak, AW; Brueggemann, M; Davi, F; Darzentas, N; van Dongen, JJM; Gonzalez, D; Cazzaniga, G; Giudicelli, V; Lefranc, MP; Giraud, M; Macintyre, EA; Hummel, M; Pott, C; Groenen, PJTA; Stamatopoulos, K, 2017: High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges. JOURNAL OF IMMUNOLOGY 198(10), p. 3765 - 3774, doi: 10.4049/jimmunol.1602050
• Pal, K; Bystry, V; Reigl, T; Demko, M; Krejci, A; Touloumenidou, T; Stalika, E; Tichy, B; Ghia, P; Stamatopoulos, K; Pospisilova, S; Malcikova, J; Darzentas, N, 2017: GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data. BIOINFORMATICS 33(23), p. 3802 - 3804, doi: 10.1093/bioinformatics/btx423
• Roy, A; Bystry, V; Bohn, G; Goudevenou, K; Reigl, T; Papaioannou, M; Krejci, A; O´Byrne, S; Chaidos, A; Grioni, A; Darzentas, N; Roberts, IAG; Karadimitris, A, 2017: High resolution IgH repertoire analysis reveals fetal liver as the likely origin of life-long, innate B lymphopoiesis in humans. CLINICAL IMMUNOLOGY 183, p. 8 - 16, doi: 10.1016/j.clim.2017.06.005
• Brhelova, E; Antonova, M; Pardy, F; Kocmanova, I; Mayer, J; Racil, Z; Lengerova, M, 2017: Investigation of next-generation sequencing data of Klebsiella pneumoniae using web-based tools. JOURNAL OF MEDICAL MICROBIOLOGY 66(11), p. 1673 - 1683, doi: 10.1099/jmm.0.000624
• Rosenquist, R; Ghia, P; Hadzidimitriou, A; Sutton, L A; Agathangelidis, A; Baliakas, P; Darzentas, N; Giudicelli, V; Lefranc M. P; Langerak, A W; Belessi, C; Davi F; Stamatopoulos, K, 2017: Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: Updated eric recommendations. LEUKEMIA , doi: 10.1038/leu.2017.125
• Kantorova, B; Malcikova, J; Brazdilova, K; Borsky, M; Plevova, K; Smardova, J; Radova, L; Tom, N; Trbusek, M; Diviskova, E; Francova, HS; Navrkalova, V; Doubek, M; Brychtova, Y; Mayer, J; Pospisilova, S, 2017: Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients. BRITISH JOURNAL OF HAEMATOLOGY 178(6), p. 979 - 982, doi: 10.1111/bjh.14176
• Zlamalikova, L; Moulis, M; Ravcukova, B; Liskova, K; Malcikova, J; Salek, D; Jarkovsky, J; Svitakova, M; Hrabalkova, R; Smarda, J; Smardova, J, 2017: Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas. ONCOLOGY REPORTS 38(4), p. 2535 - 2542, doi: 10.3892/or.2017.5891
• Ruzicka, M; Kulhanek, P; Radova, L; Cechova, A; Spackova, N; Fajkusova, L; Reblova, K, 2017: DNA mutation motifs in the genes associated with inherited diseases. PLOS ONE 12(8), doi: 10.1371/journal.pone.0182377
• Kotaskova, I; Nemec, P; Vanerkova, M; Malisova, B; Tejkalova, R; Orban, M; Zampachova, V; Freiberger, T, 2017: First report of Sneathia sanguinegens together with Mycoplasma hominis in postpartum prosthetic valve infective endocarditis: a case report. BMC INFECTIOUS DISEASES 17, doi: 10.1186/s12879-017-2654-8
• Pecimonova, M; Polak, E; Csicsay, F; Reblova, K; Stojiljkovic, M; Levarski, Z; Skultety, L; Kadasi, L; Soltysova, A, 2017: Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase. GENERAL PHYSIOLOGY AND BIOPHYSICS 36(4), p. 361 - 371, doi: 10.4149/gpb_2017003
• Jarosova, M; Hruba, M; Oltova, A; Plevova, K; Kruzova, L; Kriegova, E; Fillerova, R; Koritakova, E; Doubek, M; Lysak, D; Prochazka, V; Mraz, M; Indrak, K; Papajik, T, 2017: Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. AMERICAN JOURNAL OF HEMATOLOGY 92(10), p. E604 - E607, doi: 10.1002/ajh.24852
• Belicky, S; Cernocka, H; Bertok, T; Holazova, A; Reblova, K; Palecek, E; Tkac, J; Ostatna, V, 2017: Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins. BIOELECTROCHEMISTRY 117, p. 89 - 94, doi: 10.1016/j.bioelechem.2017.06.005
• Dubovy, P; Klusakova, I; Kucera, L; Osiclova, J; Chovancova, J; Loja, T; Mayer, J; Doubek, M; Joukal, M, 2017: Local chemical sympathectomy of rat bone marrow and its effect on marrow cell composition. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL 206, p. 19 - 27, doi: 10.1016/j.autneu.2017.06.003
• Bencurova, P; Baloun, J; Musilova, K; Radova, L; Tichy, B; Pail, M; Zeman, M; Brichtova, E; Hermanova, M; Pospisilova, S; Mraz, M; Brazdil, M, 2017: MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus. EPILEPSIA 58(10), p. 1782 - 1793, doi: 10.1111/epi.13870
• Grodecka, L; Buratti, E; Freiberger, T, 2017: Mutations of Pre-mRNA Splicing Regulatory Elements: Are Predictions Moving Forward to Clinical Diagnostics?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18(8), doi: 10.3390/ijms18081668
• Rodriguez-Vicente, AE; Bikos, V; Hernandez-Sanchez, M; Malcikova, J; Hernandez-Rivas, JM; Pospisilova, S, 2017: Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons. ONCOTARGET 8(41), p. 71234 - 71248, doi: 10.18632/oncotarget.19525
• Vardi, A; Vlachonikola, E; Karypidou, M; Stalika, E; Bikos, V; Gemenetzi, K; Maramis, C; Siorenta, A; Anagnostopoulos, A; Pospisilova, S; Maglaveras, N; Chouvarda, I; Stamatopoulos, K; Hadzidimitriou, A, 2017: Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements. LEUKEMIA 31(7), p. 1555 - 1561, doi: 10.1038/leu.2016.362
• Delgado, J; Doubek, M; Baumann, T; Kotaskova, J; Molica, S; Mozas, P; Rivas-Delgado, A.; Morabito, F; Pospisilova, S; Montserrat, E, 2017: Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI. AMERICAN JOURNAL OF HEMATOLOGY , doi: 10.1002/ajh.24660
• Young, E; Noerenberg, D; Mansouri, L; Ljungstrom, V; Frick, M; Sutton, LA; Blakemore, SJ; Galan-Sousa, J; Plevova, K; Baliakas, P; Rossi, D; Clifford, R; Roos-Weil, D; Navrkalova, V; Dorken, B; Schmitt, CA; Smedby, KE; Juliusson, G; Giacopelli, B; Blachly, JS; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Oscier, D; Schuh, A; Gaidano, G; Ghia, P; Xu, W; Fan, L; Bernard, OA; Nguyen-Khac, F; Rassenti, L; Li, J; Kipps, TJ; Stamatopoulos, K; Pospisilova, S; Zenz, T; Oakes, CC; Strefford, JC; Rosenquist, R; Damm, F, 2017: EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. LEUKEMIA 31(7), p. 1547 - 1554, doi: 10.1038/leu.2016.359

2016

• Brhelova, E; Kocmanova, I; Racil, Z; Hanslianova, M; Antonova, M; Mayer, J; Lengerova, M, 2016: Validation of Minim typing for fast and accurate discrimination of extended-spectrum, beta-lactamase-producing Klebsiella pneumoniae isolates in tertiary care hospital. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 86(1), p. 44 - 49, doi: 10.1016/j.diagmicrobio.2016.03.010
• Bronson, PG; Chang, D; Bhangale, T; Seldin, MF; Ortmannl, W; Ferreira, RC; Urcelay, E; Pereira, LF; Martin, J; Plebani, A; Lougaris, V; Friman, V; Freiberger, T; Litzman, J; Thon, V; Pan-Hammarstrom, Q; Hammarstrom, L; Graham, RR; Behrens, TW, 2016: Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency. NATURE GENETICS 48(11), p. 1425 - 1429, doi: 10.1038/ng.3675
• Melazzini, F; Palombo, F; Balduini, A; De Rocco, D; Marconi, C; Noris, P; Gnan, C; Pippucci, T; Bozzi, V; Faleschini, M; Barozzi, S; Doubek, M; Di Buduo, CA; Kozubik, KS; Radova, L; Loffredo, G; Pospisilova, S; Alfano, C; Seri, M; Balduini, CL; Pecci, A; Savoia, A, 2016: Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia. HAEMATOLOGICA 101(11), p. 1333 - 1342, doi: 10.3324/haematol.2016.147496
• Baliakas, P; Puiggros, A; Xochelli, A; Sutton, LA; Nguyen-Khac, F; Gardiner, A; Plevova, K; Minga, E; Hadzidimitriou, A; Walewska, R; McCarthy, H; Ortega, M; Collado, R; Gonzalez, T; Granada, I; Luno, E; Kotaskova, J; Moysiadis, T; Davis, Z; Stavroyianni, N; Anagnostopoulos, A; Strefford, JC; Pospisilova, S; Davi, F; Athanasiadou, A; Rosenquist, R; Oscier, D; Espinet, B; Stamatopoulos, K, 2016: Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference. HAEMATOLOGICA 101(7), p. 299 - 302, doi: 10.3324/haematol.2015.140202
• Bikos, V; Karypidou, M; Stalika, E; Baliakas, P; Xochelli, A; Sutton, LA; Papadopoulos, G; Agathangelidis, A; Papadopoulou, E; Davis, Z; Algara, P; Kanellis, G; Traverse-Glehen, A; Mollejo, M; Anagnostopoulos, A; Ponzoni, M; Gonzalez, D; Pospisilova, S; Matutes, E; Piris, MA; Papadaki, T; Ghia, P; Rosenquist, R; Oscier, D; Darzentas, N; Tzovaras, D; Belessi, C; Hadzidimitriou, A; Stamatopoulos, K, 2016: An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors. CLINICAL CANCER RESEARCH 22(8), p. 2032 - 2040, doi: 10.1158/1078-0432.CCR-15-1170
• Culen, M; Borsky, M; Nemethova, V; Razga, F; Smejkal, J; Jurcek, T; Dvorakova, D; Zackova, D; Weinbergerova, B; Semerad, L; Sadovnik, I; Eisenwort, G; Herrmann, H; Valent, P; Mayer, J; Racil, Z, 2016: Quantitative assessment of the CD26+leukemic stem cell compartment in chronic myeloid leukemia: Patient-subgroups, prognostic impact, and technical aspects. ONCOTARGET 7(22), p. 33016 - 33024, doi: 10.18632/oncotarget.9108
• Bezdicek, M; Lengerova, M; Ricna, D; Weinbergerova, B; Kocmanova, I; Volfova, P; Drgona, L; Poczova, M; Mayer, J; Racil, Z, 2016: Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis. MEDICAL MYCOLOGY 54(7), p. 714 - 724, doi: 10.1093/mmy/myw032
• Greil, R; Obrtlikova, P; Smolej, L; Kozak, T; Steurer, M; Andel, J; Burgstaller, S; Mikuskova, E; Gercheva, L; Nosslinger, T; Papajik, T; Ladicka, M; Girschikofsky, M; Hrubisko, M; Jager, U; Fridrik, M; Pecherstorfer, M; Kralikova, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochova, E; Palasthy, S; Stehlikova, O; Doubek, M; Altenhofer, P; Pleyer, L; Melchardt, T; Klingler, A; Mayer, J; Egle, A, 2016: Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial. LANCET HAEMATOLOGY 3(7), p. E317 - E329, doi: 10.1016/S2352-3026(16)30045-X
• Kotaskova, J; Pavlova, S; Greif, I; Stehlikova, O; Plevova, K; Janovska, P; Brychtova, Y; Doubek, M; Pospisilova, S; Bryja, V, 2016: ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells. BRITISH JOURNAL OF HAEMATOLOGY 175(2), p. 339 - 342, doi: 10.1111/bjh.13848
• Kopeckova, L; Buckova, H; Kyrova, J; Gaillyova, R; Nemeckova, J; Jerabkova, B; Vesely, K; Stehlikova, K; Fajkusova, L, 2016: Ten years of DNA diagnostics of epidermolysis bullosa in the Czech Republic. BRITISH JOURNAL OF DERMATOLOGY 174(6), p. 1388 - 1391, doi: 10.1111/bjd.14370
• Obrucova, H; Tihelkova, R; Kotaskova, I; Ruzicka, F; Hola, V; Nemcova, E; Freiberger, T, 2016: Evaluation of Fluorescent Capillary Electrophoresis for Rapid Identification of Candida Fungal Infections. JOURNAL OF CLINICAL MICROBIOLOGY 54(5), p. 1295 - 1303, doi: 10.1128/JCM.00118-16
• Baliakas, P; Mattsson, M; Hadzidimitriou, A; Minga, E; Agathangelidis, A; Sutton, LA; Scarfo, L; Davis, Z; Yan, XJ; Plevova, K; Sandberg, Y; Vojdeman, FJ; Tzenou, T; Chu, CC; Veroneze, S; Mansouri, L; Smedby, KE; Giudicelli, V; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Anagnostopoulos, A; Lefranc, MP; Trentin, L; Catherwood, M; Montillo, M; Niemann, CU; Langerak, AW; Pospisilova, S; Stavroyianni, N; Chiorazzi, N; Oscier, D; Jelinek, DF; Shanafelt, T; Darzentas, N; Belessi, C; Davi, F; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2016: NO IMPROVEMENT IN LONG-TERM OVERALL SURVIVAL AFTER THE INTRODUCTION OF CHEMO(IMMUNO)THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS BELONGING TO STEREOTYPED SUBSET #2. HAEMATOLOGICA 101, p. 231 - 231
• Pospisilova, S; Sutton, LA; Malcikova, J; Tausch, E; Rossi, D; Montserrat, E; Moreno, C; Stamatopoulos, K; Gaidano, G; Rosenquist, R; Ghia, P, 2016: Innovation In the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?. HAEMATOLOGICA 101(3), p. 263 - 265, doi: 10.3324/haematol.2015.139246
• Poppova, L; Janovska, P; Plevova, K; Radova, L; Plesingerova, H; Borsky, M; Kotaskova, J; Kantorova, B; Hlozkova, M; Figulova, J; Brychtova, Y; Doubek, M; Kozubik, A; Pospisilova, S; Pavlova, S; Bryja, V, 2016: DECREASED EXPRESSION OF WNT3, A CANONICAL WNT PATHWAY LIGAND, IS FREQUENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PROGRESSION AND IDENTIFIES PATIENTS WITH SHORT TREATMENT-FREE SURVIVAL IN MUTATED IGHV SUBSET. HAEMATOLOGICA 101, p. 423 - 424
• Sutton, LA; Young, E; Baliakas, P; Hadzidimitriou, A; Moysiadis, T; Plevova, K; Rossi, D; Kminkova, J; Stalika, E; Pedersen, LB; Malcikova, J; Agathangelidis, A; Davis, Z; Mansouri, L; Scarfo, L; Boudjoghra, M; Navarro, A; Muggen, AF; Yan, XJ; Nguyen-Khac, F; Larrayoz, M; Panagiotidis, P; Chiorazzi, N; Niemann, CU; Belessi, C; Campo, E; Strefford, JC; Langerak, AW; Oscier, D; Gaidano, G; Pospisilova, S; Davi, F; Ghia, P; Stamatopoulos, K; Rosenquist, R, 2016: Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. HAEMATOLOGICA 101(8), p. 959 - 967, doi: 10.3324/haematol.2016.141812
• Kopparapu, PK; Bhoi, S; Mansouri, L; Arabanian, LS; Plevova, K; Pospisilova, S; Wasik, AM; Croci, GA; Sander, B; Paulli, M; Rosenquist, R; Kanduri, M, 2016: Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression. EPIGENETICS 11(5), p. 335 - 343, doi: 10.1080/15592294.2016.1164375
• Cortes, JE; Saglio, G; Kantarjian, HM; Baccarani, M; Mayer, J; Boque, C; Shah, NP; Chuah, C; Casanova, L; Bradley-Garelik, B; Manos, G; Hochhaus, A, 2016: Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial. JOURNAL OF CLINICAL ONCOLOGY 34(20), p. 2333 - U54, doi: 10.1200/JCO.2015.64.8899
• Freiberger, T; Pavlouskova, J; Reblova, K; Tichy, L; Fajkusova, L, 2016: FUNCTIONAL ANALYSIS OF MUTATIONS LOCATED IN THE LDL RECEPTOR SIGNAL SEQUENCE CODING REGION. ATHEROSCLEROSIS 252, p. E43 - E43
• Pavlouskova, J; Reblova, K; Tichy, L; Freiberger, T; Fajkusova, L, 2016: Functional analysis of the p.(Leu15Pro) and p.(Gly20Arg) sequence changes in the signal sequence of LDL receptor. ATHEROSCLEROSIS 250, p. 9 - 14, doi: 10.1016/j.atherosclerosis.2016.04.022
• Turchaninova, MA; Davydov, A; Britanova, OV; Shugay, M; Bikos, V; Egorov, ES; Kirgizova, VI; Merzlyak, EM; Staroverov, DB; Bolotin, DA; Mamedov, IZ; Izraelson, M; Logacheva, MD; Kladova, O; Plevova, K; Pospisilova, S; Chudakov, DM, 2016: High-quality full-length immunoglobulin profiling with unique molecular barcoding. NATURE PROTOCOLS 11(9), p. 1599 - 1616, doi: 10.1038/nprot.2016.093
• Pavlasova, G; Borsky, M; Seda, V; Cerna, K; Osickova, J; Doubek, M; Mayer, J; Calogero, R; Trbusek, M; Pospisilova, S; Davids, MS; Kipps, TJ; Brown, JR; Mraz, M, 2016: Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis. BLOOD 128(12), p. 1609 - 1613, doi: 10.1182/blood-2016-04-709519
• Janovska, P; Poppova, L; Plevova, K; Plesingerova, H; Behal, M; Kaucka, M; Ovesna, P; Hlozkova, M; Borsky, M; Stehlikova, O; Brychtova, Y; Doubek, M; Machalova, M; Baskar, S; Kozubik, A; Pospisilova, S; Pavlova, S; Bryja, V, 2016: Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. CLINICAL CANCER RESEARCH 22(2), p. 459 - 469, doi: 10.1158/1078-0432.CCR-15-0154
• Buckova, H; Noskova, H; Borska, R; Reblova, K; Pinkova, B; Zapletalova, E; Kopeckova, L; Horky, O; Nemeckova, J; Gaillyova, R; Nagy, Z; Vesely, K; Hermanova, M; Stehlikova, K; Fajkusova, L, 2016: Autosomal recessive congenital ichthyoses in the Czech Republic. BRITISH JOURNAL OF DERMATOLOGY 174(2), p. 405 - 407, doi: 10.1111/bjd.13918
• Ricna, D; Lengerova, M; Palackova, M; Hadrabova, M; Kocmanova, I; Weinbergerova, B; Pavlovsky, Z; Volfova, P; Bouchnerova, J; Mayer, J; Racil, Z, 2016: Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature. MYCOSES 59(1), p. 48 - 55, doi: 10.1111/myc.12421
• Smardova, J; Liskova, K; Ravcukova, B; Malcikova, J; Hausnerova, J; Svitakova, M; Hrabalkova, R; Zlamalikova, L; Stano-Kozubik, K; Blahakova, I; Speldova, J; Jarkovsky, J; Smarda, J, 2016: Complex analysis of the p53 tumor suppressor in lung carcinoma. ONCOLOGY REPORTS 35(3), p. 1859 - 1867, doi: 10.3892/or.2015.4533
• Bousios, A; Diez, CM; Takuno, S; Bystry, V; Darzentas, N; Gaut, BS, 2016: A role for palindromic structures in the cis-region of maize Sirevirus LTRs in transposable element evolution and host epigenetic response. GENOME RESEARCH 26(2), p. 226 - 237, doi: 10.1101/gr.193763.115
• Ho, AD; Schetelig, J; Bochtler, T; Schaich, M; Schafer-Eckart, K; Hanel, M; Rosler, W; Einsele, H; Kaufmann, M; Serve, H; Berde, WE; Stelljes, M; Mayer, J; Reichle, A; Baldus, CD; Schmitz, N; Kramer, M; Rollig, C; Bornhauser, M; Thiede, C; Ehninger, G, 2016: Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 22(3), p. 462 - 469, doi: 10.1016/j.bbmt.2015.10.023
• Rawstron, AC; Fazi, C; Agathangelidis, A; Villamor, N; Letestu, R; Nomdedeu, J; Palacio, C; Stehlikova, O; Kreuzer, KA; Liptrot, S; O´Brien, D; de Tute, RM; Marinov, I; Hauwel, M; Spacek, M; Dobber, J; Kater, AP; Gambell, P; Soosapilla, A; Lozanski, G; Brachtl, G; Lin, K; Boysen, J; Hanson, C; Jorgensen, JL; Stetler-Stevenson, M; Yuan, C; Broome, HE; Rassenti, L; Craig, F; Delgado, J; Moreno, C; Bosch, F; Egle, A; Doubek, M; Pospisilova, S; Mulligan, S; Westerman, D; Sanders, CM; Emerson, R; Robins, HS; Kirsch, I; Shanafelt, T; Pettitt, A; Kipps, TJ; Wierda, WG; Cymbalista, F; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P, 2016: A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. LEUKEMIA 30(4), p. 929 - 936, doi: 10.1038/leu.2015.313
• Navrkalova, V; Young, E; Baliakas, P; Radova, L; Sutton, LA; Plevova, K; Mansouri, L; Ljungstrom, V; Ntoufa, S; Davis, Z; Juliusson, G; Smedby, KE; Belessi, C; Panagiotidis, P; Touloumenidou, T; Davi, F; Langerak, AW; Ghia, P; Strefford, JC; Oscier, D; Mayer, J; Stamatopoulos, K; Pospisilova, S; Rosenquist, R; Trbusek, M, 2016: ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. HAEMATOLOGICA 101(9), doi: 10.3324/haematol.2016.142968
• Smida, M; de la Cruz, FF; Kerzendorfer, C; Uras, IZ; Mair, B; Mazouzi, A; Suchankova, T; Konopka, T; Katz, AM; Paz, K; Nagy-Bojarszky, K; Muellner, MK; Bago-Horvath, Z; Haura, EB; Loizou, JI; Nijman, SMB, 2016: MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated. NATURE COMMUNICATIONS 7, doi: 10.1038/ncomms13701
• Poppova, L; Janovska, P; Plevova, K; Radova, L; Plesingerova, H; Borsky, M; Kotaskova, J; Kantorova, B; Hlozkova, M; Figulova, J; Brychtova, Y; Machalova, M; Urik, M; Doubek, M; Kozubik, A; Pospisilova, S; Pavlova, S; Bryja, V, 2016: Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV. BRITISH JOURNAL OF HAEMATOLOGY 175(5), p. 851 - 859, doi: 10.1111/bjh.14312
• Santos, RD; Gidding, SS; Hegele, RA; Cuchel, MA; Barter, PJ; Watts, GF; Baum, SJ; Catapano, AL; Chapman, MJ; Defesche, JC; Folco, E; Freiberger, T; Genest, J; Hovingh, GK; Harada-Shiba, M; Humphries, SE; Jackson, AS; Mata, P; Moriarty, PM; Raal, FJ; Al-Rasadi, K; Ray, KK; Reiner, Z; Sijbrands, EJG; Yamashita, S, 2016: Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. LANCET DIABETES & ENDOCRINOLOGY 4(10), p. 850 - 861, doi: 10.1016/S2213-8587(16)30041-9
• Iliev, R; Fedorko, M; Machackova, T; Mlcochova, H; Svoboda, M; Pacik, D; Dolezel, J; Stanik, M; Slaby, O, 2016: Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma. ANTICANCER RESEARCH 36(12), p. 6419 - 6423, doi: 10.21873/anticanres.11239

2015

• Reblova, K; Kulhanek, P; Fajkusova, L, 2015: Computational study of missense mutations in phenylalanine hydroxylase. JOURNAL OF MOLECULAR MODELING 21(4), doi: 10.1007/s00894-015-2620-6
• Musilova, K; Mraz, M, 2015: MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. LEUKEMIA 29(5), p. 1004 - 1017, doi: 10.1038/leu.2014.351
• te Raa, GD; Derks, IAM; Navrkalova, V; Skowronska, A; Moerland, PD; van Laar, J; Oldreive, C; Monsuur, H; Trbusek, M; Malcikova, J; Loden, M; Geisler, CH; Hullein, J; Jethwa, A; Zenz, T; Pospisilova, S; Stankovic, T; van Oers, MHJ; Kater, AP; Eldering, E, 2015: The impact of SF3B1 mutations in CLL on the DNA-damage response. LEUKEMIA 29(5), p. 1133 - 1142, doi: 10.1038/leu.2014.318
• Mansouri, L; Sutton, LA; Ljungstrom, V; Bondza, S; Arngarden, L; Bhoi, S; Larsson, J; Cortese, D; Kalushkova, A; Plevova, K; Young, E; Gunnarsson, R; Falk-Sorqvist, E; Lonn, P; Muggen, AF; Yan, XJ; Sander, B; Enblad, G; Smedby, KE; Juliusson, G; Belessi, C; Rung, J; Chiorazzi, N; Strefford, JC; Langerak, AW; Pospisilova, S; Davi, F; Hellstrom, M; Jernberg-Wiklund, H; Ghia, P; Soderberg, O; Stamatopoulos, K; Nilsson, M; Rosenquist, R, 2015: Functional loss of I kappa B epsilon leads to NF-kappa B deregulation in aggressive chronic lymphocytic leukemia. JOURNAL OF EXPERIMENTAL MEDICINE 212(6), p. 833 - 843, doi: 10.1084/jem.20142009
• Doubkova, M; Pospisil, Z; Skrickova, J; Doubek, M, 2015: Prognostic markers of sarcoidosis: an analysis of patients from everyday pneumological practice. CLINICAL RESPIRATORY JOURNAL 9(4), p. 443 - 449, doi: 10.1111/crj.12160
• Xochelli, A; Sutton, LA; Agathangelidis, A; Stalika, E; Karypidou, M; Marantidou, F; Lopez, AN; Papadopoulos, G; Supikova, J; Groenen, P; Boudjogra, M; Sundstrom, C; Ponzoni, M; Francova, HS; Anagnostopoulos, A; Pospisilova, S; Papadaki, T; Tzovaras, D; Ghia, P; Pott, C; Davi, F; Campo, E; Rosenguist, R; Hadzidimitriou, A; Belessi, C; Stamatopoulos, K, 2015: Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell Lymphoma. AMERICAN JOURNAL OF PATHOLOGY 185(6), p. 1740 - 1748, doi: 10.1016/j.ajpath.2015.02.006
• Baliakas, P; Hadzidimitriou, A; Sutton, LA; Rossi, D; Minga, E; Villamor, N; Larrayoz, M; Kminkova, J; Agathangelidis, A; Davis, Z; Tausch, E; Stalika, E; Kantorova, B; Mansouri, L; Scarfo, L; Cortese, D; Navrkalova, V; Rose-Zerilli, MJJ; Smedby, KE; Juliusson, G; Anagnostopoulos, A; Makris, AM; Navarro, A; Delgado, J; Oscier, D; Belessi, C; Stilgenbauer, S; Ghia, P; Pospisilova, S; Gaidano, G; Campo, E; Strefford, JC; Stamatopoulos, K; Rosenquist, R, 2015: Recurrent mutations refine prognosis in chronic lymphocytic leukemia. LEUKEMIA 29(2), p. 329 - 336, doi: 10.1038/leu.2014.196
• Stros, M; Polanska, E; Kucirek, M; Pospisilova, S, 2015: Histone H1 Differentially Inhibits DNA Bending by Reduced and Oxidized HMGB1 Protein. PLOS ONE 10(9), doi: 10.1371/journal.pone.0138774
• Seda, V; Mraz, M, 2015: B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. EUROPEAN JOURNAL OF HAEMATOLOGY 94(3), p. 193 - 205, doi: 10.1111/ejh.12427
• Chovancova, J; Bernard, T; Stehlikova, O; Salek, D; Janikova, A; Mayer, J; Doubek, M, 2015: Detection of Minimal Residual Disease in Mantle Cell Lymphoma-Establishment of Novel Eight-Color Flow Cytometry Approach. CYTOMETRY PART B-CLINICAL CYTOMETRY 88(2), p. 92 - 100, doi: 10.1002/cyto.b.21210
• Kantorova, B; Malcikova, J; Smardova, J; Pavlova, S; Trbusek, M; Tom, N; Plevova, K; Tichy, B; Truong, S; Diviskova, E; Kotaskova, J; Oltova, A; Patten, N; Brychtova, Y; Doubek, M; Mayer, J; Pospisilova, S, 2015: TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods. TUMOR BIOLOGY 36(5), p. 3371 - 3380, doi: 10.1007/s13277-014-2971-0
• Sutton, LA; Ljungstrom, V; Mansouri, L; Young, E; Cortese, D; Navrkalova, V; Malcikova, J; Muggen, AF; Trbusek, M; Panagiotidis, P; Davi, F; Belessi, C; Langerak, AW; Ghia, P; Pospisilova, S; Stamatopoulos, K; Rosenquist, R, 2015: Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting. HAEMATOLOGICA 100(3), p. 370 - 376, doi: 10.3324/haematol.2014.109777
• Cervinek, L; Mayer, J; Doubek, M, 2015: Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults. INTERNATIONAL JOURNAL OF HEMATOLOGY 102(1), p. 7 - 11, doi: 10.1007/s12185-015-1793-1
• te Raa, GD; Moerland, PD; Leeksma, AC; Derks, IA; Yigittop, H; Laddach, N; Loden-van Straaten, M; Navrkalova, V; Trbusek, M; Luijks, DM; Zenz, T; Skowronska, A; Hoogendoorn, M; Stankovic, T; van Oers, MH; Eldering, E; Kater, AP, 2015: Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification. CELL DEATH & DISEASE 6, doi: 10.1038/cddis.2015.223
• Trizuljak, J; Srovnal, J; Plevova, K; Brychtova, Y; Semerad, L; Bakesova, D; Letalova, E; Benedikova, A; Mayer, J; Hajduch, M; Pospisilova, S; Doubek, M, 2015: Analysis of Prognostic Significance of Merkel Cell Polyomavirus in Chronic Lymphocytic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 15(7), p. 439 - 442, doi: 10.1016/j.clml.2015.02.003
• Navrkalova, V; Kafkova, LR; Divoky, V; Pospisilova, S, 2015: Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients. HAEMATOLOGICA 100(8), p. 994 - 996, doi: 10.3324/haematol.2015.130260
• Verner, J; Trbusek, M; Chovancova, J; Jaskova, Z; Moulis, M; Folber, F; Halouzka, R; Mayer, J; Pospisilova, S; Doubek, M, 2015: NOD/SCID IL2R gamma-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines. LEUKEMIA & LYMPHOMA 56(11), p. 3198 - 3206, doi: 10.3109/10428194.2015.1034701
• Reblova, M; Reblova, K; Stepanek, V, 2015: Molecular systematics of Barbatosphaeria (Sordariomycetes): multigene phylogeny and secondary ITS structure. PERSOONIA 35, p. 21 - 38, doi: 10.3767/003158515X687434
• Jeziskova, I; Musilova, M; Culen, M; Foltankova, V; Dvorakova, D; Mayer, J; Racil, Z, 2015: Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML. INTERNATIONAL JOURNAL OF HEMATOLOGY 102(5), p. 553 - 557, doi: 10.1007/s12185-015-1856-3
• Doubek, M; Smida, M, 2015: Treatment of chronic lymphocytic leukemia with monoclonal antibodies, where are we heading?. EXPERT REVIEW OF HEMATOLOGY 8(6), p. 743 - 764, doi: 10.1586/17474086.2015.1079123
• Reblova, M; Jaklitsch, WM; Reblova, K; Stepanek, V, 2015: Phylogenetic Reconstruction of the Calosphaeriales and Togniniales Using Five Genes and Predicted RNA Secondary Structures of ITS, and Flabellascus tenuirostris gen. et sp nov.. PLOS ONE 10(12), doi: 10.1371/journal.pone.0144616
• Baliakas, P; Hadzidimitriou, A; Agathangelidis, A; Rossi, D; Sutton, LA; Kminkova, J; Scarfo, L; Pospisilova, S; Gaidano, G; Stamatopoulos, K; Ghia, P; Rosenquist, R, 2015: Prognostic relevance of MYD88 mutations in CLL: the jury is still out. BLOOD 126(8), p. 1043 - 1044, doi: 10.1182/blood-2015-05-648634
• Chu, VH; Park, LP; Athan, E; Delahaye, F; Freiberger, T; Lamas, C; Miro, JM; Mudrick, DW; Strahilevitz, J; Tribouilloy, C; Durante-Mangoni, E; Pericas, JM; Fernandez-Hidalgo, N; Nacinovich, F; Rizk, H; Krajinovic, V; Giannitsioti, E; Hurley, JP; Hannan, MM; Wang, A, 2015: Response to Letter Regarding Article, ´Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis´. CIRCULATION 132(14), p. E184 - E185, doi: 10.1161/CIRCULATIONAHA.115.016782
• Nemcova, E; Cernochova, M; Ruzicka, F; Malisova, B; Freiberger, T; Nemec, P, 2015: Rapid Identification of Medically Important Candida Isolates Using High Resolution Melting Analysis. PLOS ONE 10(2), doi: 10.1371/journal.pone.0116940
• Chu, VH; Park, LP; Athan, E; Delahaye, F; Freiberger, T; Lamas, C; Miro, JM; Mudrick, DW; Strahilevitz, J; Tribouilloy, C; Durante-Mangoni, E; Pericas, JM; Fernandez-Hidalgo, N; Nacinovich, F; Rizk, H; Krajinovic, V; Giannitsioti, E; Hurley, JP; Hannan, MM; Wang, A, 2015: Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis A Prospective Study From the International Collaboration on Endocarditis. CIRCULATION 131(2), p. 131 - U46, doi: 10.1161/CIRCULATIONAHA.114.012461
• Krizova, L; McGinnis, J; Maixnerova, M; Nemec, M; Poirel, L; Mingle, L; Sedo, O; Wolfgang, W; Nemec, A, 2015: Acinetobacter variabilis sp nov (formerly DNA group 15 sensu Tjernberg & Ursing), isolated from humans and animals. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY 65, p. 857 - 863, doi: 10.1099/ijs.0.000028
• Sripathi, KN; Banas, P; Reblova, K; Sponer, J; Otyepka, M; Walter, NG, 2015: Wobble pairs of the HDV ribozyme play specific roles in stabilization of active site dynamics. PHYSICAL CHEMISTRY CHEMICAL PHYSICS 17(8), p. 5887 - 5900, doi: 10.1039/c4cp05083e
• Baliakas, P; Strefford, JC; Bikos, V; Parry, M; Stamatopoulos, K; Oscier, D, 2015: Splenic marginal-zone lymphoma: ontogeny and genetics. LEUKEMIA & LYMPHOMA 56(2), p. 301 - 310, doi: 10.3109/10428194.2014.919636
• Bystry, V; Agathangelidis, A; Bikos, V; Sutton, LA; Baliakas, P; Hadzidimitriou, A; Stamatopoulos, K; Darzentas, N, 2015: ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy. BIOINFORMATICS 31(23), p. 3844 - 3846, doi: 10.1093/bioinformatics/btv456
• Xochelli, A; Agathangelidis, A; Kavakiotis, I; Minga, E; Sutton, L; Baliakas, P; Chouvarda, I; Giudicelli, V; Vlahavas, I; Maglaveras, N; Bonello, L; Trentin, L; Tedeschi, A; Panagiotidis, P; Geisler, C; Langerak, A; Pospisilova, S; Jelinek, D; Oscier, D; Chiorazzi, N; Darzentas, N; Davi, F; Ghia, P; Rosenquist, R; Hadzidimitriou, A; Belessi, C; Lefranc, MP; Stamatopoulos, K, 2015: Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia. IMMUNOGENETICS 67(1), p. 61 - 66, doi: 10.1007/s00251-014-0812-3
• Baliakas, P; Agathangelidis, A; Hadzidimitriou, A; Sutton, LA; Minga, E; Tsanousa, A; Scarfo, L; Davis, Z; Yan, XJ; Shanafelt, T; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjogra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, A; Mansouri, L; Smedby, KE; Pedersen, LB; Moreno, D; Van Lom, K; Giudicelli, V; Francova, HS; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2015: Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. BLOOD 125(5), p. 856 - 859, doi: 10.1182/blood-2014-09-600874
• Malcikova, J; Stano-Kozubik, K; Tichy, B; Kantorova, B; Pavlova, S; Tom, N; Radova, L; Smardova, J; Pardy, F; Doubek, M; Brychtova, Y; Mraz, M; Plevova, K; Diviskova, E; Oltova, A; Mayer, J; Pospisilova, S; Trbusek, M, 2015: Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. LEUKEMIA 29(4), p. 877 - 885, doi: 10.1038/leu.2014.297

2014

• Vardi, A; Agathangelidis, A; Sutton, LA; Chatzouli, M; Scarfo, L; Mansouri, L; Douka, V; Anagnostopoulos, A; Darzentas, N; Rosenquist, R; Ghia, P; Belessi, C; Stamatopoulos, K, 2014: IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications. CLINICAL CANCER RESEARCH 20(2), p. 323 - 330, doi: 10.1158/1078-0432.CCR-13-1993
• te Raa, GD; Malcikova, J; Mraz, M; Trbusek, M; Le Garff-Tavernier, M; Merle-Beral, H; Greil, R; Merkel, O; Pospisilova, S; Lin, K; Pettitt, AR; Stankovic, T; van Oers, MH; Eldering, E; Stilgenbauer, S; Zenz, T; Kater, AP, 2014: Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach. BRITISH JOURNAL OF HAEMATOLOGY 167(4), p. 565 - 569, doi: 10.1111/bjh.13006
• Shugay, M; Britanova, OV; Merzlyak, EM; Turchaninova, MA; Mamedov, IZ; Tuganbaev, TR; Bolotin, DA; Staroverov, DB; Putintseva, EV; Plevova, K; Linnemann, C; Shagin, D; Pospisilova, S; Lukyanov, S; Schumacher, TN; Chudakov, DM, 2014: Towards error-free profiling of immune repertoires. NATURE METHODS 11(6), p. 653 - +, doi: 10.1038/NMETH.2960
• Fiegl, M; Stauder, R; Steurer, M; Mian, M; Hopfinger, G; Brychtova, Y; Skrabs, C; Zabernigg, A; Schmid, F; Haslbaur, F; Winder, G; Walder, A; Lang, A; Voskova, D; Greil, R; Mayer, J; Gastl, G, 2014: Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. ANNALS OF HEMATOLOGY 93(2), p. 267 - 277, doi: 10.1007/s00277-013-1966-z
• Musilova, M; Razga, F; Jurcek, T; Jeziskova, I; Borsky, M; Nemethova, V; Zackova, D; Culen, M; Dvorakova, D; Mayer, J; Racil, Z, 2014: BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing. AMERICAN JOURNAL OF HEMATOLOGY 89(10), p. 1016 - 1017, doi: 10.1002/ajh.23794
• Kminkova, J; Mraz, M; Zaprazna, K; Navrkalova, V; Tichy, B; Plevova, K; Malcikova, J; Cerna, K; Rausch, T; Benes, V; Brychtova, Y; Doubek, M; Mayer, J; Pospisilova, S, 2014: Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia. CARCINOGENESIS 35(5), p. 992 - 1002, doi: 10.1093/carcin/bgt396
• Stehlikova, K; Skalova, D; Zidkova, J; Mrazova, L; Vondracek, P; Mazanec, R; Vohanka, S; Haberlova, J; Hermanova, M; Zamecnik, J; Soucek, O; Oslejskova, H; Dvorackova, N; Solarova, P; Fajkusova, L, 2014: Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic. BMC NEUROLOGY 14, doi: 10.1186/s12883-014-0154-7
• Polanska, E; Pospisilova, S; Stros, M, 2014: Binding of Histone H1 to DNA Is Differentially Modulated by Redox State of HMGB1. PLOS ONE 9(2), doi: 10.1371/journal.pone.0089070
• Stehlikova, K; Skalova, D; Hruba, Z; Fajkusova, L, 2014: Limb girdle muscular dystrophy in the Czech Republic. NEUROMUSCULAR DISORDERS 24(42286), p. 883 - 883, doi: 10.1016/j.nmd.2014.06.298
• Benner, A; Mansouri, L; Rossi, D; Majid, A; Willander, K; Parker, A; Bond, G; Pavlova, S; Nuckel, H; Merkel, O; Ghia, P; Montserrat, E; Kaderi, MA; Rosenquist, R; Gaidano, G; Dyer, MJS; Soderkvist, P; Linderholm, M; Oscier, D; Tvaruzkova, Z; Pospisilova, , 2014: MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis. HAEMATOLOGICA 99(8), p. 1285 - 1291, doi: 10.3324/haematol.2013.101170
• Plevova, K; Francova, HS; Burckova, K; Brychtova, Y; Doubek, M; Pavlova, S; Malcikova, J; Mayer, J; Tichy, B; Pospisilova, S, 2014: Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. HAEMATOLOGICA 99(2), p. 329 - 338, doi: 10.3324/haematol.2013.087593
• Mayer, J; Arthur, C; Delaunay, J; Mazur, G; Thomas, XG; Wierzbowska, A; Ravandi, F; Berrak, E; Jones, M; Li, YH; Kantarjian, HM, 2014: Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor-or intermediate-risk cytogenetics. BMC CANCER 14, doi: 10.1186/1471-2407-14-69
• Baliakas, P; Iskas, M; Gardiner, A; Davis, Z; Plevova, K; Florence, NK; Malcikova, J; Anagnostopoulos, A; Glide, S; Mould, S; Stepanovska, K; Brejcha, M; Belessi, C; Davi, F; Pospisilova, S; Athanasiadou, A; Stamatopoulos, K; Oscier, D, 2014: Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data. AMERICAN JOURNAL OF HEMATOLOGY 89(3), p. 249 - 255, doi: 10.1002/ajh.23618
• Brejcha, M; Stoklasova, M; Brychtova, Y; Panovska, A; Stepanovska, K; Vankova, G; Plevova, K; Oltova, A; Horka, K; Pospisilova, S; Mayer, J; Doubek, M, 2014: Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis. LEUKEMIA RESEARCH 38(2), p. 170 - 175, doi: 10.1016/j.leukres.2013.10.019
• Stehlikova, O; Chovancova, J; Tichy, B; Krejci, M; Brychtova, Y; Panovska, A; Skuhrova, HF; Burckova, K; Borsky, M; Loja, T; Mayer, J; Pospisilova, S; Doubek, M, 2014: Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 36(2), p. 165 - 171, doi: 10.1111/ijlh.12149
• Volfova, P; Lengerova, M; Lochmanova, J; Dvorakova, D; Ricna, D; Palackova, M; Weinbergerova, B; Mayer, J; Racil, Z, 2014: Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCR. JOURNAL OF CLINICAL VIROLOGY 61(2), p. 270 - 274, doi: 10.1016/j.jcv.2014.07.008
• Potesil, D; Stejskal, S; Borsky, M; Simara, P; Havelkova, M; Razga, F; Koutna, I; Dvorakova, D; Mayer, J; Racil, Z; Zdrahal, Z, 2014: Determination of Imatinib in the Blood Cells of Chronic Myelogenous Leukemia Patients by Ion-Trap Mass Spectrometry. ANALYTICAL LETTERS 47(6), p. 944 - 957, doi: 10.1080/00032719.2013.860538
• Sebejova, L; Borsky, M; Jaskova, Z; Potesil, D; Navrkalova, V; Malcikova, J; Sramek, M; Doubek, M; Loja, T; Pospisilova, S; Mayer, J; Trbusek, M, 2014: Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab. EXPERIMENTAL HEMATOLOGY 42(10), p. 867 - 874, doi: 10.1016/j.exphem.2014.06.003
• Jabbour, E; Kantarjian, HM; Saglio, G; Steegmann, JL; Shah, NP; Boque, C; Chuah, C; Pavlovsky, C; Mayer, J; Cortes, J; Baccarani, M; Kim, DW; Bradley-Garelik, MB; Mohamed, H; Wildgust, M; Hochhaus, A, 2014: Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). BLOOD 123(4), p. 494 - 500, doi: 10.1182/blood-2013-06-511592
• Racil, Z; Razga, F; Klamova, H; Voglova, J; Belohlavkova, P; Malaskova, L; Potesil, D; Muzik, J; Zackova, D; Polakova, KM; Zdrahal, Z; Malakova, J; Suttnar, J; Dyr, J; Mayer, J, 2014: No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia. HEMATOLOGICAL ONCOLOGY 32(2), p. 87 - 93, doi: 10.1002/hon.2091
• Malcikova, J; Pavlova, S; Kozubik, KS; Pospisilova, S, 2014: TP53 Mutation Analysis in Clinical Practice: Lessons From Chronic Lymphocytic Leukemia. HUMAN MUTATION 35(6), p. 663 - 671, doi: 10.1002/humu.22508
• Janikova, A; Mareckova, A; Baumeisterova, A; Krejci, M; Supikova, J; Salek, D; Horky, O; Tichy, B; Hanke, I; Pospisilova, S; Moulis, M; Mayer, J, 2014: Transmission of t(11;14)-positive cells by allogeneic stem cell transplant: 10-year journey to mantle cell lymphoma. LEUKEMIA & LYMPHOMA 55(8), p. 1935 - 1938, doi: 10.3109/10428194.2013.858150
• Robesova, B; Bajerova, M; Liskova, K; Skrickova, J; Tomiskova, M; Pospisilova, S; Mayer, J; Dvorakova, D, 2014: TaqMan based real time PCR assay targeting EML4-ALK fusion transcripts in NSCLC. LUNG CANCER 85(1), p. 25 - 30, doi: 10.1016/j.lungcan.2014.04.002
• Malcikova, J; Stalika, E; Davis, Z; Plevova, K; Trbusek, M; Mansouri, L; Scarfo, L; Baliakas, P; Gardiner, A; Sutton, LA; Francova, HS; Agathangelidis, A; Anagnostopoulos, A; Tracy, I; Makris, A; Smardova, J; Ghia, P; Belessi, C; Gonzalez, D; Rosenquist, , 2014: The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors. BRITISH JOURNAL OF HAEMATOLOGY 166(4), p. 621 - 625, doi: 10.1111/bjh.12893
• Lengerova, M; Racil, Z; Hrncirova, K; Kocmanova, I; Volfova, P; Ricna, D; Bejdak, P; Moulis, M; Pavlovsky, Z; Weinbergerova, B; Toskova, M; Mayer, J, 2014: Rapid Detection and Identification of Mucormycetes in Bronchoalveolar Lavage Samples from Immunocompromised Patients with Pulmonary Infiltrates by Use of High-Resolution Melt Analysis. JOURNAL OF CLINICAL MICROBIOLOGY 52(8), p. 2824 - 2828, doi: 10.1128/JCM.00637-14
• Jurcek, T; Razga, F; Mazancova, P; Musilova, M; Dvorakova, D; Borsky, M; Zackova, D; Dobesova, B; Semerad, L; Mayer, J; Racil, Z, 2014: Prospective analysis of low-level BCR-ABL1 T315I mutation in CD34+ cells of patients with de novo chronic myeloid leukemia. LEUKEMIA & LYMPHOMA 55(8), p. 1915 - 1917, doi: 10.3109/10428194.2013.842988

2013

• Racil, Z; Toskova, M; Kocmanova, I; Buresova, L; Kouba, M; Drgona, L; Masarova, L; Guman, T; Tothova, E; Gabzdilova, J; Forsterova, K; Haber, J; Ziakova, B; Bojtarova, E; Rolencova, M; Timilsina, S; Cetkovsky, P; Mayer, J, 2013: Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics. LEUKEMIA & LYMPHOMA 54(5), p. 1042 - 1047, doi: 10.3109/10428194.2012.729057
• Coiffier, B; Li, WM; Henitz, ED; Karkera, JD; Favis, R; Gaffney, D; Shapiro, A; Theocharous, P; Elsayed, YA; van de Velde, H; Schaffer, ME; Osmanov, EA; Hong, XN; Scheliga, A; Mayer, J; Offner, F; Rule, S; Teixeira, A; Romejko-Jarosinska, J; de Vos, S; Cr, 2013: Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab. CLINICAL CANCER RESEARCH 19(9), p. 2551 - 2561, doi: 10.1158/1078-0432.CCR-12-3069
• Adam, Z; Szturz, P; Vanicek, J; Moulis, M; Pour, L; Krejci, M; Hajek, R; Mayer, J, 2013: Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. ACTA ONCOLOGICA 52(5), p. 994 - 1001, doi: 10.3109/0284186X.2012.716164
• Dvorakova, D; Racil, Z; Borsky, M; Robesova, B; Jeziskova, I; Razga, F; Lengerova, M; Mayer, J, 2013: Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutations. LEUKEMIA & LYMPHOMA 54(5), p. 1056 - 1060, doi: 10.3109/10428194.2012.734618
• Szturz, P; Adam, Z; Vasku, V; Feit, J; Krejci, M; Pour, L; Hajek, R; Mayer, J, 2013: Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. LEUKEMIA & LYMPHOMA 54(6), p. 1324 - 1326, doi: 10.3109/10428194.2012.738816
• Schaich, M; Parmentier, S; Kramer, M; Illmer, T; Stolzel, F; Rollig, C; Thiede, C; Hanel, M; Schafer-Eckart, K; Aulitzky, W; Einsele, H; Ho, AD; Serve, H; Berdel, WE; Mayer, J; Schmitz, N; Krause, SW; Neubauer, A; Baldus, CD; Schetelig, J; Bornhaeuser, M;, 2013: High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 Trial. JOURNAL OF CLINICAL ONCOLOGY 31(17), p. 2094 - +, doi: 10.1200/JCO.2012.46.4743
• Pfeiffer, T; Schleuning, M; Mayer, J; Haude, KH; Tischer, J; Buchholz, S; Bunjes, D; Bug, G; Holler, E; Meyer, RG; Greinix, H; Scheid, C; Christopeit, M; Schnittger, S; Braess, J; Schlimok, G; Spiekermann, K; Ganser, A; Kolb, HJ; Schmid, C, 2013: Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse. HAEMATOLOGICA 98(4), p. 518 - 525, doi: 10.3324/haematol.2012.070235
• Racil, Z; Weinbergerova, B; Kocmanova, I; Muzik, J; Kouba, M; Drgona, L; Masarova, L; Gumang, T; Tothova, E; Forsterova, K; Haber, J; Ziakova, B; Bojtarova, E; Vydra, J; Mudry, P; Foralova, R; Sejnova, D; Mallatova, N; Kandrnal, V; Cetkovsky, P; Mayer, J, 2013: Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 17(2), p. E101 - E109, doi: 10.1016/j.ijid.2012.09.004
• Toskova, M; Palousova, D; Kocmanova, I; Pavlovsky, Z; Timilsina, S; Lengerova, M; Mayer, J; Racil, Z, 2013: Invasive mould disease involving the gastrointestinal tract caused by Neosartorya pseudofischeri in a haematological patient. MYCOSES 56(3), p. 385 - 388, doi: 10.1111/myc.12038
• Krejci, M; Doubek, M; Dusek, J; Brychtova, Y; Racil, Z; Navratil, M; Tomiska, M; Horky, O; Pospisilova, S; Mayer, J, 2013: Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. ANNALS OF HEMATOLOGY 92(10), p. 1397 - 1403, doi: 10.1007/s00277-013-1790-5
• Racil, Z; Razga, F; Drapalova, J; Buresova, L; Zackova, D; Palackova, M; Semerad, L; Malaskova, L; Haluzik, M; Mayer, J, 2013: Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia. HAEMATOLOGICA 98(10), doi: 10.3324/haematol.2013.086355
• Doubkova, M; Doubek, M; Moulis, M; Skirickova, J, 2013: Exogenous lipoid pneumonia caused by chronic improper use of baby body oil in adult patient. REVISTA PORTUGUESA DE PNEUMOLOGIA 19(5), p. 233 - 236, doi: 10.1016/j.rppneu.2013.05.002
• Jeziskova, I; Razga, F; Toskova, M; Dvorakova, D; Timilsina, S; Mayer, J; Racil, Z, 2013: Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene. LEUKEMIA & LYMPHOMA 54(4), p. 867 - 870, doi: 10.3109/10428194.2012.727414
• Zackova, D; Klamova, H; Muzik, J; Cmunt, E; Racil, Z; Polakova, KM; Dvorakova, D; Jurcek, T; Razga, F; Cetkovsky, P; Dusek, L; Mayer, J, 2013: Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. LEUKEMIA & LYMPHOMA 54(10), p. 2310 - 2313, doi: 10.3109/10428194.2013.772173
• Baccarani, M; Deininger, MW; Rosti, G; Hochhaus, A; Soverini, S; Apperley, JF; Cervantes, F; Clark, RE; Cortes, JE; Guilhot, F; Hjorth-Hansen, H; Hughes, TP; Kantarjian, HM; Kim, DW; Larson, RA; Lipton, JH; Mahon, FX; Martinelli, G; Mayer, J; Muller, MC; , 2013: European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. BLOOD 122(6), p. 872 - 884, doi: 10.1182/blood-2013-05-501569
• Pavlik, T; Janousova, E; Mayer, J; Indrak, K; Jarosova, M; Klamova, H; Zackova, D; Voglova, J; Faber, E; Karas, M; Polakova, KM; Racil, Z; Demeckova, E; Demitrovicova, L; Tothova, E; Chudej, J; Markuljak, I; Cmunt, E; Kozak, T; Muzik, J; Dusek, L, 2013: Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications. AMERICAN JOURNAL OF HEMATOLOGY 88(9), p. 790 - 797, doi: 10.1002/ajh.23508
• Fink, AM; Bottcher, S; Ritgen, M; Fischer, K; Pflug, N; Eichhorst, B; Wendtner, CM; Winkler, D; Buhler, A; Zenz, T; Staib, P; Mayer, J; Hensel, M; Hopfinger, G; Wenger, M; Fingerle-Rowson, G; Dohner, H; Kneba, M; Stilgenbauer, S; Busch, R; Hallek, M, 2013: Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. LEUKEMIA 27(9), p. 1949 - 1952, doi: 10.1038/leu.2013.190
• Simara, P; Stejskal, S; Koutna, I; Potesil, D; Tesarova, L; Potesilova, M; Zdrahal, Z; Mayer, J, 2013: Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition. AMERICAN JOURNAL OF HEMATOLOGY 88(5), p. 385 - 393, doi: 10.1002/ajh.23419
• Navrkalova, V; Sebejova, L; Zemanova, J; Kminkova, J; Kubesova, B; Malcikova, J; Mraz, M; Smardova, J; Pavlova, S; Doubek, M; Brychtova, Y; Potesil, D; Nemethova, V; Mayer, J; Pospisilova, S; Trbusek, M, 2013: ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin. HAEMATOLOGICA 98(7), p. 1124 - 1131, doi: 10.3324/haematol.2012.081620
• Krejci, M; Doubek, M; Brychtova, Y; Stehlikova, O; Chovancova, J; Tichy, B; Francova, HS; Navratil, M; Tomiska, M; Horky, O; Pospisilova, S; Mayer, J, 2013: Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia. ANNALS OF HEMATOLOGY 92(2), p. 249 - 254, doi: 10.1007/s00277-012-1579-y
• Panovska, A; Smolej, L; Lysak, D; Brychtova, Y; Simkovic, M; Motyckova, M; Vodarek, P; Lindtnerova, M; Trbusek, M; Malcikova, J; Pospisilova, S; Mayer, J; Doubek, M, 2013: The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab. EUROPEAN JOURNAL OF HAEMATOLOGY 90(6), p. 479 - 485, doi: 10.1111/ejh.12106
• Darzentas, N; Stamatopoulos, K, 2013: The Significance of Stereotyped B-Cell Receptors in Chronic Lymphocytic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 27(2), p. 237 - +, doi: 10.1016/j.hoc.2012.12.001
• Bousios, A; Darzentas, N, 2013: Sirevirus LTR retrotransposons: phylogenetic misconceptions in the plant world. MOBILE DNA 4, p. 1 - 7, doi: 10.1186/1759-8753-4-9
• Khare, V; Lyakhovich, A; Dammann, K; Lang, M; Borgmann, M; Tichy, B; Pospisilova, S; Luciani, G; Campregher, C; Evstatiev, R; Pflueger, M; Hundsberger, H; Gasche, C, 2013: Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1. BIOCHEMICAL PHARMACOLOGY 85(2), p. 234 - 244, doi: 10.1016/j.bcp.2012.10.026
• ROBESOVA, B.;M. BAJEROVA;A. VASIKOVA;L. OSTRIZKOVA;J. HAUSNEROVA;J. KYCLOVA;S. POSPISILOVA;J. MAYER;D. DVORAKOVA., 2013: Molekularne biologicka diagnostika mutaci genu KRAS a BRAF u pacientu s kolorektalnim karcinomem - zkusenosti laboratorniho pracoviste. KLINICKA ONKOLOGIE 26, p. 25 - 30
• te Raa, GD; Malcikova, J; Pospisilova, S; Trbusek, M; Mraz, M; Le Garff-Tavernier, M; Merle-Beral, H; Lin, K; Pettitt, AR; Merkel, O; Stankovic, T; van Oers, MH; Eldering, E; Stilgenbauer, S; Zenz, T; Kater, AP, 2013: Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA 54(8), p. 1849 - 1853, doi: 10.3109/10428194.2013.796058
• Mraz, M; Kozubik, KS; Plevova, K; Musilova, K; Tichy, B; Borsky, M; Kuglik, P; Doubek, M; Brychtova, Y; Mayer, J; Pospisilova, S, 2013: The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. LEUKEMIA RESEARCH 37(7), p. 802 - 808, doi: 10.1016/j.leukres.2013.03.018
• Kaucka, M; Plevova, K; Pavlova, S; Janovska, P; Mishra, A; Verner, J; Prochazkova, J; Krejci, P; Kotaskova, J; Ovesna, P; Tichy, B; Brychtova, Y; Doubek, M; Kozubik, A; Mayer, J; Pospisilova, S; Bryja, V, 2013: The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration. CANCER RESEARCH 73(5), p. 1491 - 1501, doi: 10.1158/0008-5472CAN-12-1752
• Klampfl, T; Milosevic, JD; Puda, A; Schonegger, A; Bagienski, K; Berg, T; Harutyunyan, AS; Gisslinger, B; Rumi, E; Malcovati, L; Pietra, D; Elena, C; Della Porta, MG; Pieri, L; Guglielmelli, P; Bock, C; Doubek, M; Dvorakova, D; Suvajdzic, N; Tomin, D; Tos, 2013: Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. PLOS ONE 8(10), doi: 10.1371/journal.pone.0077819
• Racil, Z; Kocmanova, I; Toskova, M; Winterova, J; Lengerova, M; Timilsina, S; Mayer, J, 2013: Reactivity of the 1,3-beta-D-glucan assay during bacteraemia: limited evidence from a prospective study. MYCOSES 56(2), p. 101 - 104, doi: 10.1111/j.1439-0507.2012.02210.x
• Strefford, JC; Sutton, LA; Baliakas, P; Agathangelidis, A; Malcikova, J; Plevova, K; Scarfo, L; Davis, Z; Stalika, E; Cortese, D; Cahill, N; Pedersen, LB; di Celle, PF; Tzenou, T; Geisler, C; Panagiotidis, P; Langerak, AW; Chiorazzi, N; Pospisilova, S; Os, 2013: Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. LEUKEMIA 27(11), p. 2196 - 2199, doi: 10.1038/leu.2013.98
• Hoffmann, VS; Baccarani, M; Lindoerfer, D; Castagnetti, F; Turkina, A; Zaritsky, A; Hellmann, A; Prejzner, W; Steegmann, JL; Mayer, J; Indrak, K; Colita, A; Rosti, G; Pfirrmann, M, 2013: The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib. LEUKEMIA 27(10), p. 2016 - 2022, doi: 10.1038/leu.2013.171
• Sutton, LA; Agathangelidis, A; Belessi, C; Darzentas, N; Davi, F; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2013: Antigen selection in B-cell lymphomas-Tracing the evidence. SEMINARS IN CANCER BIOLOGY 23(6), p. 399 - 409, doi: 10.1016/j.semcancer.2013.07.006
• Sutton, LA; Kostareli, E; Stalika, E; Tsaftaris, A; Anagnostopoulos, A; Darzentas, N; Rosenquist, R; Stamatopoulos, K, 2013: Temporal Dynamics of Clonal Evolution in Chronic Lymphocytic Leukemia with Stereotyped IGHV4-34/IGKV2-30 Antigen Receptors: Longitudinal Immunogenetic Evidence. MOLECULAR MEDICINE 19, p. 230 - 236, doi: 10.2119/molmed.2013.00042
• Skalova, D; Zidkova, J; Vohanka, S; Mazanec, R; Musova, Z; Vondracek, P; Mrazova, L; Kraus, J; Reblova, K; Fajkusova, L, 2013: CLCN1 Mutations in Czech Patients with Myotonia Congenita, In Silico Analysis of Novel and Known Mutations in the Human Dimeric Skeletal Muscle Chloride Channel. PLOS ONE 8(12), doi: 10.1371/journal.pone.0082549
• Vancikova, Z; Freiberger, T; Vach, W; Trojanek, M; Rizzi, M; Janda, A, 2013: X-linked Agammaglobulinemia in Community-acquired Pneumonia Cases Revealed by Immunoglobulin Level Screening at Hospital Admission. KLINISCHE PADIATRIE 225(6), p. 339 - 342, doi: 10.1055/s-0033-1354415
• Reblova, M; Untereiner, WA; Reblova, K, 2013: Novel Evolutionary Lineages Revealed in the Chaetothyriales (Fungi) Based on Multigene Phylogenetic Analyses and Comparison of ITS Secondary Structure. PLOS ONE 8(5), doi: 10.1371/journal.pone.0063547
• Krepl, M; Reblova, K; Koca, J; Sponer, J, 2013: Bioinformatics and Molecular Dynamics Simulation Study of L1 Stalk Non-Canonical rRNA Elements: Kink-Turns, Loops, and Tetraloops. JOURNAL OF PHYSICAL CHEMISTRY B 117(18), p. 5540 - 5555, doi: 10.1021/jp401482m
• Reblova, M; Reblova, K, 2013: RNA secondary structure, an important bioinformatics tool to enhance multiple sequence alignment: a case study (Sordariomycetes, Fungi). MYCOLOGICAL PROGRESS 12(2), p. 305 - 319, doi: 10.1007/s11557-012-0836-8
• Malcikova, J; Razga, F; Jurcek, T; Dvorakova, D; Zackova, D; Toskova, M; Sebejova, L; Smardova, J; Oltova, A; Vankova, G; Jurackova, L; Trbusek, M; Pospisilova, S; Mayer, J; Racil, Z, 2013: The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy. LEUKEMIA & LYMPHOMA 54(9), p. 2083 - 2087, doi: 10.3109/10428194.2012.762649

2012

• Szturz, P; Adam, Z; Chovancova, J; Stehlikova, O; Klabusay, M; Rehak, Z; Koukalova, R; Krejci, M; Pour, L; Zahradova, L; Hajek, R; Mayer, J, 2012: Lenalidomide: a new treatment option for Castleman disease. LEUKEMIA & LYMPHOMA 53(10), p. 2089 - 2091, doi: 10.3109/10428194.2011.621564
• Szturz, P; Rehak, Z; Koukalova, R; Adam, Z; Krejci, M; Pour, L; Zahradova, L; Vanicek, J; Nebesky, T; Hajek, R; Mayer, J, 2012: Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. NUCLEAR MEDICINE AND BIOLOGY 39(3), p. 429 - 436, doi: 10.1016/j.nucmedbio.2011.10.002
• Finke, J; Schmoor, C; Bethge, WA; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhauser, M; Einsele, H; Bertz, H; Grishina, O; Socie, G, 2012: Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 18(11), p. 1716 - 1726, doi: 10.1016/j.bbmt.2012.06.001
• Szturz, P; Adam, Z; Rehak, Z; Koukalova, R; Slaisova, R; Stehlikova, O; Chovancova, J; Klabusay, M; Krejci, M; Pour, L; Hajek, R; Mayer, J, 2012: Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. ACTA ONCOLOGICA 51(3), p. 412 - U148, doi: 10.3109/0284186X.2011.631581
• Szturz, P; Adam, Z; Chovancova, J; Stehlikova, O; Klabusay, M; Feit, J; Kren, L; Fojtik, Z; Krejci, M; Pour, L; Hajek, R; Mayer, J, 2012: Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. LEUKEMIA & LYMPHOMA 53(4), p. 743 - 745, doi: 10.3109/10428194.2011.627482
• Krejci, M; Kamelander, J; Pospisil, Z; Mayer, J, 2012: Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host disease. NEOPLASMA 59(3), p. 264 - 268, doi: 10.4149/neo_2012_034
• Racil, Z; Toskova, M; Dvorakova, D; Jeziskova, I; Razga, F; Buresova, L; Timilsina, S; Mayer, J, 2012: Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy. AMERICAN JOURNAL OF HEMATOLOGY 87(2), p. 211 - 213, doi: 10.1002/ajh.22213
• Racil, Z; Winterova, J; Kouba, M; Zak, P; Malaskova, L; Buresova, L; Toskova, M; Lengerova, M; Kocmanova, I; Weinbergerova, B; Timilsina, S; Rolencova, M; Cetkovsky, P; Mayer, J, 2012: Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience. MYCOSES 55(6), p. 483 - 492, doi: 10.1111/j.1439-0507.2012.02186.x
• Kantarjian, HM; Thomas, XG; Dmoszynska, A; Wierzbowska, A; Mazur, G; Mayer, J; Gau, JP; Chou, WC; Buckstein, R; Cermak, J; Kuo, CY; Oriol, A; Ravandi, F; Faderl, S; Delaunay, J; Lysak, D; Minden, M; Arthur, C, 2012: Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia. JOURNAL OF CLINICAL ONCOLOGY 30(21), p. 2670 - 2677, doi: 10.1200/JCO.2011.38.9429
• Ponzoni, M; Kanellis, G; Pouliou, E; Baliakas, P; Scarfo, L; Ferreri, AJM; Doglioni, C; Bikos, V; Dagklis, A; Anagnostopoulos, A; Ghia, P; Stamatopoulos, K; Papadaki, T, 2012: Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY 36(11), p. 1609 - 1618, doi: 10.1097/PAS.0b013e318271243d
• Cornelissen, JJ; Gratwohl, A; Schlenk, RF; Sierra, J; Bornhauser, M; Juliusson, G; Racil, Z; Rowe, JM; Russell, N; Mohty, M; Lowenberg, B; Socie, G; Niederwieser, D; Ossenkoppele, GJ, 2012: The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. NATURE REVIEWS CLINICAL ONCOLOGY 9(10), p. 579 - 590, doi: 10.1038/nrclinonc.2012.150
• Volfova, P; Lengerova, M; Winterova, J; Racil, Z; Dvorakova, D; Mayer, J, 2012: Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation. INFECTION 40(5), p. 583 - 587, doi: 10.1007/s15010-012-0262-5
• Pospisilova, S; Gonzalez, D; Malcikova, J; Trbusek, M; Rossi, D; Kater, AP; Cymbalista, F; Eichhorst, B; Hallek, M; Dohner, H; Hillmen, P; van Oers, M; Gribben, J; Ghia, P; Montserrat, E; Stilgenbauer, S; Zenz, T, 2012: ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. LEUKEMIA 26(7), p. 1458 - 1461, doi: 10.1038/leu.2012.25
• Janikova, A; Mareckova, A; Dvorakova, D; Bortlicek, Z; Tichy, B; Navratil, M; Kral, Z; Pospisilova, S; Mayer, J, 2012: A real-time (PCR) for a real life ...? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice. EXPERIMENTAL HEMATOLOGY 40(7), p. 528 - 539, doi: 10.1016/j.exphem.2012.02.005
• Kostareli, E; Gounari, M; Janus, A; Murray, F; Brochet, X; Giudicelli, V; Pospisilova, S; Oscier, D; Foroni, L; di Celle, PF; Tichy, B; Pedersen, LB; Jurlander, J; Ponzoni, M; Kouvatsi, A; Anagnostopoulos, A; Thompson, K; Darzentas, N; Lefranc, MP; Beless, 2012: Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity. LEUKEMIA 26(5), p. 1127 - 1131, doi: 10.1038/leu.2011.311
• Agathangelidis, A; Darzentas, N; Hadzidimitriou, A; Brochet, X; Murray, F; Yan, XJ; Davis, Z; van Gastel-Mol, EJ; Tresoldi, C; Chu, CC; Cahill, N; Giudicelli, V; Tichy, B; Pedersen, LB; Foroni, L; Bonello, L; Janus, A; Smedby, K; Anagnostopoulos, A; Merle, 2012: Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. BLOOD 119(19), p. 4467 - 4475, doi: 10.1182/blood-2011-11-393694
• Bousios, A; Minga, E; Kalitsou, N; Pantermali, M; Tsaballa, A; Darzentas, N, 2012: MASiVEdb: the Sirevirus Plant Retrotransposon Database. BMC GENOMICS 13, doi: 10.1186/1471-2164-13-158
• Bousios, A; Kourmpetis, YAI; Pavlidis, P; Minga, E; Tsaftaris, A; Darzentas, N, 2012: The turbulent life of Sirevirus retrotransposons and the evolution of the maize genome: more than ten thousand elements tell the story. PLANT JOURNAL 69(3), p. 475 - 488, doi: 10.1111/j.1365-313X.2011.04806.x
• Verner, J; Kabathova, J; Tomancova, A; Pavlova, S; Tichy, B; Mraz, M; Brychtova, Y; Krejci, M; Zdrahal, Z; Trbusek, M; Volejnikova, J; Sedlacek, P; Doubek, M; Mayer, J; Pospisilova, S, 2012: Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation. EXPERIMENTAL HEMATOLOGY 40(11), p. 899 - 905, doi: 10.1016/j.exphem.2012.06.011
• Lochmanova, G; Jedlickova, L; Potesil, D; Tomancova, A; Verner, J; Pospisilova, S; Doubek, M; Mayer, J; Zdrahal, Z, 2012: Potential biomarkers for early detection of acute graft-versus-host disease. PROTEOMICS CLINICAL APPLICATIONS 6(42223), p. 351 - 363, doi: 10.1002/prca.201100104
• Doubek, M; Trbusek, M; Malcikova, J; Brychtova, Y; Smardova, J; Lochmanova, J; Panovska, A; Francova, HS; Mraz, M; Tichy, B; Sebejova, L; Navrkalova, V; Plevova, K; Kuglik, P; Mayer, J; Pospisilova, S, 2012: Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA 53(9), p. 1817 - 1819, doi: 10.3109/10428194.2012.658794
• Cervinek, L; Cerna, O; Caniga, M; Konirova, E; Hlusi, A; Simkovic, M; Pospisil, Z; Cermak, J; Kozak, T; Mayer, J; Doubek, M, 2012: Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice. INTERNATIONAL JOURNAL OF HEMATOLOGY 96(5), p. 594 - 599, doi: 10.1007/s12185-012-1206-7
• Puda, A; Milosevic, JD; Berg, T; Klampfl, T; Harutyunyan, AS; Gisslinger, B; Rumi, E; Pietra, D; Malcovati, L; Elena, C; Doubek, M; Steurer, M; Tosic, N; Pavlovic, S; Guglielmelli, P; Pieri, L; Vannucchi, AM; Gisslinger, H; Cazzola, M; Kralovics, R, 2012: Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. AMERICAN JOURNAL OF HEMATOLOGY 87(3), p. 245 - 250, doi: 10.1002/ajh.22257
• Zapletalova, D; Andre, N; Deak, L; Kyr, M; Bajciova, V; Mudry, P; Dubska, L; Demlova, R; Pavelka, Z; Zitterbart, K; Skotakova, J; Husek, K; Martincekova, A; Mazanek, P; Kepak, T; Doubek, M; Kutnikova, L; Valik, D; Sterba, J, 2012: Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience. ONCOLOGY 82(5), p. 249 - 260, doi: 10.1159/000336483
• Smolej, L; Doubek, M; Panovska, A; Simkovic, M; Brychtova, Y; Belada, D; Motyckova, M; Mayer, J, 2012: Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia. LEUKEMIA RESEARCH 36(10), p. 1278 - 1282, doi: 10.1016/j.leukres.2012.07.005
• Ganopoulos, I; Madesis, P; Darzentas, N; Argiriou, A; Tsaftaris, A, 2012: Barcode High Resolution Melting (Bar-HRM) analysis for detection and quantification of PDO ´Fava Santorinis´ (Lathyrus clymenum) adulterants. FOOD CHEMISTRY 133(2), p. 505 - 512, doi: 10.1016/j.foodchem.2012.01.015
• Navarro, A; Clot, G; Royo, C; Jares, P; Hadzidimitriou, A; Agathangelidis, A; Bikos, V; Darzentas, N; Papadaki, T; Salaverria, I; Pinyol, M; Puig, X; Palomero, J; Vegliante, MC; Amador, V; Martinez-Trillos, A; Stefancikova, L; Wiestner, A; Wilson, W; Pott, 2012: Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features. CANCER RESEARCH 72(20), p. 5307 - 5316, doi: 10.1158/0008-5472.CAN-12-1615
• Bikos, V; Darzentas, N; Hadzidimitriou, A; Davis, Z; Hockley, S; Traverse-Glehen, A; Algara, P; Santoro, A; Gonzalez, D; Mollejo, M; Dagklis, A; Gangemi, F; Bosler, DS; Bourikas, G; Anagnostopoulos, A; Tsaftaris, A; Iannitto, E; Ponzoni, M; Felman, P; Ber, 2012: Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. LEUKEMIA 26(7), p. 1638 - 1646, doi: 10.1038/leu.2012.3
• Bikos, V; Stalika, E; Baliakas, P; Darzentas, N; Davis, Z; Traverse-Glehen, A; Dagklis, A; Kanellis, G; Anagnostopoulos, A; Tsaftaris, A; Ponzoni, M; Berger, F; Felman, P; Ghia, P; Papadaki, T; Oscier, D; Belessi, C; Stamatopoulos, K, 2012: Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire. LEUKEMIA 26(12), p. 2567 - 2569, doi: 10.1038/leu.2012.207
• Milosevic, JD; Puda, A; Malcovati, L; Berg, T; Hofbauer, M; Stukalov, A; Klampfl, T; Harutyunyan, AS; Gisslinger, H; Gisslinger, B; Burjanivova, T; Rumi, E; Pietra, D; Elena, C; Vannucchi, AM; Doubek, M; Dvorakova, D; Robesova, B; Wieser, R; Koller, E; Su, 2012: Clinical significance of genetic aberrations in secondary acute myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY 87(11), p. 1010 - 1016, doi: 10.1002/ajh.23309
• Mraz, M; Dolezalova, D; Plevova, K; Kozubik, KS; Mayerova, V; Cerna, K; Musilova, K; Tichy, B; Pavlova, S; Borsky, M; Verner, J; Doubek, M; Brychtova, Y; Trbusek, M; Hampl, A; Mayer, J; Pospisilova, S, 2012: MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. BLOOD 119(9), p. 2110 - 2113, doi: 10.1182/blood-2011-11-394874
• Mraz, M; Pospisilova, S, 2012: MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. EXPERT REVIEW OF HEMATOLOGY 5(6), p. 579 - 581, doi: 10.1586/EHM.12.54
• Dolezalova, D; Mraz, M; Barta, T; Plevova, K; Vinarsky, V; Holubcova, Z; Jaros, J; Dvorak, P; Pospisilova, S; Hampl, A, 2012: MicroRNAs Regulate p21(Waf1/Cip1) Protein Expression and the DNA Damage Response in Human Embryonic Stem Cells. STEM CELLS 30(7), p. 1362 - 1372, doi: 10.1002/stem.1108
• Simara, P; Peterkova, M; Stejskal, S; Potesilova, M; Koutna, I; Racil, Z; Razga, F; Jurcek, T; Dvorakova, D; Mayer, J, 2012: BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response. LEUKEMIA & LYMPHOMA 53(8), p. 1627 - 1629, doi: 10.3109/10428194.2012.656104
• Guilhot, J; Baccarani, M; Clark, RE; Cervantes, F; Guilhot, F; Hochhaus, A; Kulikov, S; Mayer, J; Petzer, AL; Rosti, G; Rousselot, P; Saglio, G; Saussele, S; Simonsson, B; Steegmann, JL; Zaritskey, A; Hehlmann, R, 2012: Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet. BLOOD 119(25), p. 5963 - 5971, doi: 10.1182/blood-2011-10-383711
• Lengerova, M; Kocmanova, I; Racil, Z; Hrncirova, K; Pospisilova, S; Mayer, J; Najvar, LK; Wiederhold, NP; Kirkpatrick, WR; Patterson, TF, 2012: Detection and Measurement of Fungal Burden in a Guinea Pig Model of Invasive Pulmonary Aspergillosis by Novel Quantitative Nested Real-Time PCR Compared with Galactomannan and (1,3)-beta-D-Glucan Detection. JOURNAL OF CLINICAL MICROBIOLOGY 50(3), p. 602 - 608, doi: 10.1128/JCM.05356-11
• Cincarova, L; Lochmanova, G; Novakova, K; Sultesova, P; Konecna, H; Fajkusova, L; Fajkus, J; Zdrahal, Z, 2012: A combined approach for the study of histone deacetylase inhibitors. MOLECULAR BIOSYSTEMS 8(11), p. 2937 - 2945, doi: 10.1039/c2mb25136a
• Tichy, L; Freiberger, T; Zapletalova, P; Soska, V; Ravcukova, B; Fajkusova, L, 2012: The molecular basis of familial hypercholesterolemia in the Czech Republic: Spectrum of LDLR mutations and genotype-phenotype correlations. ATHEROSCLEROSIS 223(2), p. 401 - 408, doi: 10.1016/j.atherosclerosis.2012.05.014
• Lukas, Z; Falk, M; Feit, J; Soucek, O; Falkova, I; Stefancikova, L; Janousova, E; Fajkusova, L; Zaoralkova, J; Hrabalkova, R, 2012: Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2. NEUROMUSCULAR DISORDERS 22(7), p. 604 - 616, doi: 10.1016/j.nmd.2012.03.004
• Mejstrikova, E; Janda, A; Hrusak, O; Buckova, H; Vlckova, M; Hancarova, M; Freiberger, T; Ravcukova, B; Vesely, K; Fajkusova, L; Kopeckova, L; Sumerauer, D; Kabickova, E; Sediva, A; Stary, J; Sedlacek, Z, 2012: Skin Lesions in a Boy With X-linked Lymphoproliferative Disorder: Comparison of 5 SH2D1A Deletion Cases. PEDIATRICS 129(2), p. E523 - E528, doi: 10.1542/peds.2011-0870
• Soska, V; Jarkovsky, J; Ravcukova, B; Tichy, L; Fajkusova, L; Freiberger, T, 2012: The logarithm of the triglyceride/HDL-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia. CLINICAL BIOCHEMISTRY 45(42036), p. 96 - 100, doi: 10.1016/j.clinbiochem.2011.11.001

2011

• Hadzidimitriou, A; Agathangelidis, A; Darzentas, N; Murray, F; Delfau-Larue, MH; Pedersen, LB; Lopez, AN; Dagklis, A; Rombout, P; Beldjord, K; Kolstad, A; Dreyling, MH; Anagnostopoulos, A; Tsaftaris, A; Mavragani-Tsipidou, P; Rosenwald, A; Ponzoni, M; Gro, 2011: Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. BLOOD 118(11), p. 3088 - 3095, doi: 10.1182/blood-2011-03-343434
• Krejci, M; Brychtova, Y; Doubek, M; Tomiska, M; Navratil, M; Racil, Z; Dvorakova, D; Horky, O; Lengerova, M; Pospisilova, S; Mayer, J, 2011: Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. NEOPLASMA 58(5), p. 406 - 414, doi: 10.4149/neo_2011_05_406
• Fiegl, M; Falkner, F; Steurer, M; Zojer, N; Hopfinger, G; Haslbauer, F; Winder, G; Voskova, D; Andel, J; Lang, A; Brychtova, Y; Mayer, J; Greil, R; Gastl, G, 2011: Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. ANNALS OF HEMATOLOGY 90(9), p. 1083 - 1091, doi: 10.1007/s00277-011-1192-5
• Basak, GW; Jaksic, O; Koristek, Z; Mikala, G; Mayer, J; Masszi, T; Labar, B; Wiktor-Jedrzejczak, W, 2011: Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization. AMERICAN JOURNAL OF HEMATOLOGY 86(7), p. 550 - 553, doi: 10.1002/ajh.22038
• Razga, F; Racil, Z; Polakova, KM; Buresova, L; Klamova, H; Zackova, D; Dvorakova, D; Polivkova, V; Cetkovsky, P; Mayer, J, 2011: The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia. INTERNATIONAL JOURNAL OF HEMATOLOGY 94(3), p. 303 - 306, doi: 10.1007/s12185-011-0924-6
• Pavlik, T; Janousova, E; Pospisil, Z; Muzik, J; Zackova, D; Racil, Z; Klamova, H; Cetkovsky, P; Trneny, M; Mayer, J; Dusek, L, 2011: Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy. BMC MEDICAL RESEARCH METHODOLOGY 11, doi: 10.1186/1471-2288-11-140
• Socie, G; Schmoor, C; Bethge, WA; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Ruutu, T; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhauser, M; Einsele, H; Kolb, HJ; Bertz, H; Egger, M; Grishina, , 2011: Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. BLOOD 117(23), p. 6375 - 6382, doi: 10.1182/blood-2011-01-329821
• Coiffier, B; Osmanov, EA; Hong, XN; Scheliga, A; Mayer, J; Offner, F; Rule, S; Teixeira, A; Walewski, J; de Vos, S; Crump, M; Shpilberg, O; Esseltine, DL; Zhu, E; Enny, C; Theocharous, P; van de Velde, H; Elsayed, YA; Zinzani, PL, 2011: Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. LANCET ONCOLOGY 12(8), p. 773 - 784, doi: 10.1016/S1470-2045(11)70150-4
• Vargova, K; Curik, N; Burda, P; Basova, P; Kulvait, V; Pospisil, V; Savvulidi, F; Kokavec, J; Necas, E; Berkova, A; Obrtlikova, P; Karban, J; Mraz, M; Pospisilova, S; Mayer, J; Trneny, M; Zavadil, J; Stopka, T, 2011: MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. BLOOD 117(14), p. 3816 - 3825, doi: 10.1182/blood-2010-05-285064
• van der Fits, L; Sandberg, Y; Darzentas, N; Zoutman, WH; Tielemans, D; Wolvers-Tettero, ILM; Vermeer, MH; Langerak, AW, 2011: A restricted clonal T-cell receptor alpha beta repertoire in Sezary syndrome is indicative of superantigenic stimulation. BRITISH JOURNAL OF DERMATOLOGY 165(1), p. 78 - 84, doi: 10.1111/j.1365-2133.2011.10308.x
• Mraz, M; Zent, CS; Church, AK; Jelinek, DF; Wu, XS; Pospisilova, S; Ansell, SM; Novak, AJ; Kay, NE; Witzig, TE; Nowakowski, GS, 2011: Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance. BRITISH JOURNAL OF HAEMATOLOGY 155(1), p. 53 - 64, doi: 10.1111/j.1365-2141.2011.08794.x
• Janikova, A; Tichy, B; Supikova, J; Stano-Kozubik, K; Pospisilova, S; Kren, L; Vasova, I; Salek, D; Mayer, J, 2011: Gene expression profiling in follicular lymphoma and its implication for clinical practice. LEUKEMIA & LYMPHOMA 52(1), p. 59 - 68, doi: 10.3109/10428194.2010.531412
• Tsaftaris, A; Pasentsis, K; Makris, A; Darzentas, N; Policloros, A; Kalivas, A; Argiriou, A, 2011: The study of the E-class SEPALLATA3-like MADS-box genes in wild-type and mutant flowers of cultivated saffron crocus (Crocus sativus L.) and its putative progenitors. JOURNAL OF PLANT PHYSIOLOGY 168(14), p. 1675 - 1684, doi: 10.1016/.j.jplph.2011.03.015
• Tani, E; Tsaballa, A; Stedel, C; Kalloniati, C; Papaefthimiou, D; Polidoros, A; Darzentas, N; Ganopoulos, I; Flemetakis, E; Katinakis, P; Tsaftaris, A, 2011: The study of a SPATULA-like bHLH transcription factor expressed during peach (Prunus persica) fruit development. PLANT PHYSIOLOGY AND BIOCHEMISTRY 49(6), p. 654 - 663, doi: 10.1016/j.plaphy.2011.01.020
• Trbusek, M; Smardova, J; Malcikova, J; Sebejova, L; Dobes, P; Svitakova, M; Vranova, V; Mraz, M; Francova, HS; Doubek, M; Brychtova, Y; Kuglik, P; Pospisilova, S; Mayer, J, 2011: Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia. JOURNAL OF CLINICAL ONCOLOGY 29(19), p. 2703 - 2708, doi: 10.1200/JCO.2011.34.7872
• Tsaballa, A; Pasentsis, K; Darzentas, N; Tsaftaris, AS, 2011: Multiple evidence for the role of an Ovate-like gene in determining fruit shape in pepper. BMC PLANT BIOLOGY 11, doi: 10.1186/1471-2229-11-46
• Theodosiou, T; Vizirianakis, IS; Angelis, L; Tsaftaris, A; Darzentas, N, 2011: MeSHy: Mining unanticipated PubMed information using frequencies of occurrences and concurrences of MeSH terms. JOURNAL OF BIOMEDICAL INFORMATICS 44(6), p. 919 - 926, doi: 10.1016/j.jbi.2011.05.009
• Mocikova, H; Pytlik, R; Markova, J; Steinerova, K; Kral, Z; Belada, D; Trnkova, M; Trneny, M; Koza, V; Mayer, J; Zak, P; Kozak, T, 2011: Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma. LEUKEMIA & LYMPHOMA 52(9), p. 1668 - 1674, doi: 10.3109/10428194.2011.573889
• Krejci, M; Gregora, E; Straub, J; Minarik, J; Scudla, V; Adam, Z; Krivanova, A; Pour, L; Zahradova, L; Buchler, T; Mayer, J; Hajek, R, 2011: Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma. ANNALS OF HEMATOLOGY 90(12), p. 1441 - 1447, doi: 10.1007/s00277-011-1206-3
• Doubek, M; Mayer, J; Obrtlikova, P; Smolej, L; Cmunt, E; Schwarz, J; Brejcha, M; Kozmon, P; Pospisilova, S; Brychtova, Y; Pospisil, Z; Trneny, M, 2011: Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. EUROPEAN JOURNAL OF HAEMATOLOGY 87(2), p. 130 - 137, doi: 10.1111/j.1600-0609.2011.01639.x
• Kaucka, M; Krejci, P; Plevova, K; Pavlova, S; Prochazkova, J; Janovska, P; Valnohova, J; Kozubik, A; Pospisilova, S; Bryja, V, 2011: Post-translational modifications regulate signalling by Ror1. ACTA PHYSIOLOGICA 203(3), p. 351 - 362, doi: 10.1111/j.1748-1716.2011.02306.x
• Szturz, P; Adam, Z; Klincova, M; Feit, J; Krejci, M; Pour, L; Zahradova, L; Vasku, V; Hajek, R; Mayer, J, 2011: Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 11(6), p. 517 - 520, doi: 10.1016/j.clml.2011.06.014
• Basak, GW; Mikala, G; Koristek, Z; Jaksic, O; Basic-Kinda, S; Cegledi, A; Reti, M; Masszi, T; Mayer, J; Giebel, S; Hubel, K; Labar, B; Wiktor-Jedrzejczak, W, 2011: Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it´s not too late. LEUKEMIA & LYMPHOMA 52(9), p. 1711 - 1719, doi: 10.3109/10428194.2011.578312
• Racil, Z; Buresova, L; Brejcha, M; Prochazkova, J; Zounar, R; Timilsina, S; Razga, F; Toskova, M; Cetkovsky, P; Mayer, J, 2011: Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients. AMERICAN JOURNAL OF HEMATOLOGY 86(9), p. 800 - 803, doi: 10.1002/ajh.22100
• Walewski, J; Paszkiewicz-Kozik, E; Warszewska, A; Borsaru, G; Moicean, A; Hellmann, A; Mayer, J; Hauns, B; Mais, A; Henning, SW; Hentsch, B, 2011: Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma. BLOOD 118(21), p. 1149 - 1149
• Racil, Z; Kocmanova, I; Toskova, M; Buresova, L; Weinbergerova, B; Lengerova, M; Rolencova, M; Winterova, J; Hrncirova, K; Volfova, P; Skrickova, J; Mayer, J, 2011: Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 15(12), p. E874 - E881, doi: 10.1016/j.ijid.2011.09.011
• Vrzalova, Z; Hruba, Z; Hrabincova, ES; Vrabelova, S; Votava, F; Kolouskova, S; Fajkusova, L, 2011: Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia. EUROPEAN JOURNAL OF MEDICAL GENETICS 54(2), p. 112 - 117, doi: 10.1016/j.ejmg.2010.10.005
• Trbusek, M; Malcikova, J; Mayer, J, 2011: Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia. LEUKEMIA RESEARCH 35(7), p. 981 - 982, doi: 10.1016/j.leukres.2011.02.005
• Reblova, K; Sponer, JE; Spackova, N; Besseova, I; Sponer, J, 2011: A-Minor Tertiary Interactions in RNA Kink-Turns. Molecular Dynamics and Quantum Chemical Analysis. JOURNAL OF PHYSICAL CHEMISTRY B 115(47), p. 13897 - 13910, doi: 10.1021/jp2065584

2010

• Kantarjian, H; Shah, NP; Hochhaus, A; Cortes, J; Shah, S; Ayala, M; Moiraghi, B; Shen, ZX; Mayer, J; Pasquini, R; Nakamae, H; Huguet, F; Boque, C; Chuah, C; Bleickardt, E; Bradley-Garelik, MB; Zhu, C; Szatrowski, T; Shapiro, D; Baccarani, M, 2010: Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia. NEW ENGLAND JOURNAL OF MEDICINE 362(24), p. 2260 - 2270, doi: 10.1056/NEJMoa1002315
• Barta, Tomas; Vinarsky, Vladimir; Holubcova, Zuzana; Dolezalova, Dasa; Verner, Jan; Pospisilova, Sarka; Dvorak, Petr; Hampl, Ales, 2010: Human Embryonic Stem Cells Are Capable of Executing G1/S Checkpoint Activation. STEM CELLS 28(7), p. 1143 - 1152, doi: 10.1002/stem.451
• Hallek, M; Fischer, K; Fingerle-Rowson, G; Fink, AM; Busch, R; Mayer, J; Hensel, M; Hopfinger, G; Hess, G; von Grunhagen, U; Bergmann, M; Catalano, J; Zinzani, PL; Caligaris-Cappio, F; Seymour, JF; Berrebi, A; Jager, U; Cazin, B; Trneny, M; Westermann, A; Wendtner, CM; Eichhorst, BF; Staib, P; Buhler, A; Winkler, D; Zenz, T; Bottcher, S; Ritgen, M; Mendila, M; Kneba, M; Dohner, H; Stilgenbauer, S, 2010: Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. LANCET 376(9747), p. 1164 - 1174, doi: 10.1016/S0140-6736(10)61381-5
• Malcikova, J; Tichy, B; Damborsky, J; Kabathova, J; Trbusek, M; Mayer, J; Pospisilova, S, 2010: Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation. BIOLOGICAL CHEMISTRY 391(2 III), p. 197 - 205, doi: 10.1515/BC.2010.027
• Fiegl, M; Erdel, M; Tinhofer, I; Brychtova, Y; Panovska, A; Doubek, M; Eigenberger, K; Fonatsch, C; Hopfinger, G; Muhlberger, H; Zabernigg, A; Falkner, F; Gastl, G; Mayer, J; Greil, R, 2010: Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. ANNALS OF ONCOLOGY 21(12), p. 2410 - 2419, doi: 10.1093/annonc/mdq236
• Darzentas, N, 2010: Circoletto: visualizing sequence similarity with Circos. BIOINFORMATICS 26(20), p. 2620 - 2621, doi: 10.1093/bioinformatics/btq484
• Bousios, A; Darzentas, N; Tsaftaris, A; Pearce, SR, 2010: Highly conserved motifs in non-coding regions of Sirevirus retrotransposons: the key for their pattern of distribution within and across plants?. BMC GENOMICS 11, doi: 10.1186/1471-2164-11-89
• Darzentas, N; Hadzidimitriou, A; Murray, F; Hatzi, K; Josefsson, P; Laoutaris, N; Moreno, C; Anagnostopoulos, A; Jurlander, J; Tsaftaris, A; Chiorazzi, N; Belessi, C; Ghia, P; Rosenquist, R; Davi, F; Stamatopoulos, K, 2010: A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. LEUKEMIA 24(1), p. 125 - 132, doi: 10.1038/leu.2009.186
• Kotaskova, Jana; Tichy, Boris; Trbusek, Martin; Francova, Hana Skuhrova; Kabathova, Jitka; Malcikova, Jitka; Doubek, Michael; Brychtova, Yvona; Mayer, Jiri; Pospisilova, Sarka, 2010: High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated lmmunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival. JOURNAL OF MOLECULAR DIAGNOSTICS 12(3), p. 328 - 334, doi: 10.2353/jmoldx.2010.090100
• White, HE; Matejtschuk, P; Rigsby, P; Gabert, J; Lin, F; Wang, YL; Branford, S; Muller, MC; Beaufils, N; Beillard, E; Colomer, D; Dvorakova, D; Ehrencrona, H; Goh, HG; El Housni, H; Jones, D; Kairisto, V; Kamel-Reid, S; Kim, DW; Langabeer, S; Ma, ESK; Press, RD; Romeo, G; Wang, LH; Zoi, K; Hughes, T; Saglio, G; Hochhaus, A; Goldman, JM; Metcalfe, P; Cross, NCP, 2010: Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. BLOOD 116(22), p. E111 - E117, doi: 10.1182/blood-2010-06-291641
• Giebel, S; Stella-Holowiecka, B; Krawczyk-Kulis, M; Gokbuget, N; Hoelzer, D; Doubek, M; Mayer, J; Piatkowska-Jakubas, B; Skotnicki, AB; Dombret, H; Ribera, JM; Piccaluga, PP; Czerw, T; Kyrcz-Krzemien, S; Holowiecki, J, 2010: Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL. BONE MARROW TRANSPLANTATION 45(6), p. 1095 - 1101, doi: 10.1038/bmt.2009.308
• Forconi, F; Potter, KN; Wheatley, I; Darzentas, N; Sozzi, E; Stamatopoulos, K; Mockridge, CI; Packham, G; Stevenson, FK, 2010: The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. BLOOD 115(1), p. 71 - 77, doi: 10.1182/blood-2009-06-225813
• Kostareli, E; Sutton, LA; Hadzidimitriou, A; Darzentas, N; Kouvatsi, A; Tsaftaris, A; Anagnostopoulos, A; Rosenquist, R; Stamatopoulos, K, 2010: Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution. LEUKEMIA 24(7), p. 1317 - 1324, doi: 10.1038/leu.2010.90
• Darzentas, N; Bousios, A; Apostolidou, V; Tsaftaris, AS, 2010: MASiVE: Mapping and Analysis of SireVirus Elements in plant genome sequences. BIOINFORMATICS 26(19), p. 2452 - 2454, doi: 10.1093/bioinformatics/btq454
• Hrncirova, Kristyna; Lengerova, Martina; Kocmanova, Iva; Racil, Zdenek; Volfova, Pavlina; Palousova, Dita; Moulis, Mojmir; Weinbergerova, Barbora; Winterova, Jana; Toskova, Martina; Pospisilova, Sarka; Mayer, Jiri, 2010: Rapid Detection and Identification of Mucormycetes from Culture and Tissue Samples by Use of High-Resolution Melt Analysis. JOURNAL OF CLINICAL MICROBIOLOGY 48(9), p. 3392 - 3394, doi: 10.1128/JCM.01109-10
• Zenz, T; Vollmer, D; Trbusek, M; Smardova, J; Benner, A; Soussi, T; Helfrich, H; Heuberger, M; Hoth, P; Fuge, M; Denzel, T; Habe, S; Malcikova, J; Kuglik, P; Truong, S; Patten, N; Wu, L; Oscier, D; Ibbotson, R; Gardiner, A; Tracy, I; Lin, K; Pettitt, A; Pospisilova, S; Mayer, J; Hallek, M; Dohner, H; Stilgenbauer, S, 2010: TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. LEUKEMIA 24(12), p. 2072 - 2079, doi: 10.1038/leu.2010.208
• Jerabkova, B; Kopeckova, L; Buckova, H; Vesely, K; Valickova, J; Fajkusova, L, 2010: Analysis of the COL7A1 gene in Czech patients with dystrophic epidermolysis bullosa reveals novel and recurrent mutations. JOURNAL OF DERMATOLOGICAL SCIENCE 59(2), p. 136 - 140, doi: 10.1016/j.jdermsci.2010.05.007
• Jerabkova, B; Marek, J; Buckova, H; Kopeckova, L; Vesely, K; Valickova, J; Fajkus, J; Fajkusova, L, 2010: Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure. BRITISH JOURNAL OF DERMATOLOGY 162(5), p. 1004 - 1013, doi: 10.1111/j.1365-2133.2009.09626.x
• Vrzalova, Z; Hruba, Z; Hrabincova, ES; Pouchla, S; Votava, F; Kolouskova, S; Fajkusova, L, 2010: Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 26(4), p. 595 - 603, doi: 10.3892/ijmm_00000504
• Goldmann, R; Tichy, L; Freiberger, T; Zapletalova, P; Letocha, O; Soska, V; Fajkus, J; Fajkusova, L, 2010: Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia. BMC MEDICAL GENETICS 11, doi: 10.1186/1471-2350-11-115

2009

• CEJKOVA, S., ROCNOVA, L., POTESIL, D., SMARDOVA, J., NOVAKOVA, V., CHUMCHALOVA, J., ZEZULKOVA, D., BORSKY, M., DOUBEK, M., BRYCHTOVA, Y., POSPISILOVA, S., KLABUSAY, M., MAYER, K., TRBUSEK, M., 2009: Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. EUROPEAN JOURNAL OF HAEMATOLOGY , p. 133 - 142
• MRAZ, M., MALINOVA, K., KOTASKOVA, J., PAVLOVA, S., TICHY, B., MALCIKOVA, J., STANO-KOZUBIK, K., SMARDOVA, J., BRYCHTOVA, Y., DOUBEK, M., TRBUSEK, M., MAYER, J., POSPISILOVA, S., 2009: miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. LEUKEMIA 23(6), p. 1159 - 1163
• STROS, M., POLANSKA, E., STRUNCOVA, S., POSPISILOVA, S., 2009: HMGB1 and HMGB2 proteins up regulate cellular expression of human topoisomerase II alpha. NUCLEIC ACIDS RESEARCH 37(7), p. 2070 - 2086
• MALCIKOVA, J., SMARDOVA, J., ROCNOVA, L., TICHY, B., KUGLIK, P., VRANOVA, V., CEJKOVA, S., SVITAKOVA, M., SKUHROVA FRANCOVA, H., BRYCHTOVA, Y., DOUBEK, M., BREJCHA, M., KLABUSAY, M., MAYER, J., POSPISILOVA, S., TRBUSEK, M., 2009: Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival and response to DNA damage. BLOOD 114(26), p. 5307 - 5314
• Mraz, Marek; Malinova, Karla; Pavlova, Sarka; Tichy, Boris; Kozubik, Katerina Stano; Malcikova, Jitka; Borsky, Marek; Verner, Jan; Doubek, Michael; Brychtova, Yvona; Trbusek, Martin; Mayer, Jiri; Pospisilova, Sarka, 2009: Detail Characterization of 22q11 Deletion and Mir-650 Role in CLL Patients. BLOOD 114(22), p. 507 - 508
• SEDLACKOVA, J., VONDRACEK, P., HERMANOVA, M., ZAMECNIK, J., HRUBA, Z., HABERLOVA, J., KRAUS, J., MARIKOVA, T., HEDVICAKOVA, P., VOHANKA, S., FAJKUSOVA, L., 2009: Point mutations in Czech DMD/BMD patients and their phenotypic outcome. NEUROMUSCULAR DISORDERS 19(11), p. 749 - 753